integral institute of medical sciences & research, … · 2021. 3. 1. · integral institute of...
TRANSCRIPT
Ref. No:- IIMS&R/DO/2021/ Date :- 05.02.21
Sports and Extra-curricular
activitiesOB AETCOM Medicine Pandemic module
8:00AM - 9:00AM 9:00AM - 10.00AM 10.00-11.00 AM 11.00-12.00 AM 12:00 - 1:00 PM 2:00 PM - 3:00 PM 3:00 PM - 4:00 PM 4:30 PM - 5:30 PM
01-03-21 Mon
PH 1.1.1 - PH 1.1.12
Define and describe the principles
of pharmacology and
pharmacotherapeutics
Lecture
MI 1.1.1
Introduction to medical
Microbiology and bacterial
taxonomy
Lecture
FM1.1
Demonstrate knowledge of
basics of Forensic Medicine
like
definitions of Forensic
medicine, Clinical Forensic
Medicine,
Forensic Pathology, State
Medicine, Legal Medicine
and Medical Jurisprudence
Lecture FM 1.1.1, FM1.2
Describe history of
Forensic Medicine FM 1.2.1
Lecture
PH1.9- Describe
nomenclature of drugs i.e.
generic, branded drugs
Lecture
Sports and Extra-curricular activities
02-03-21 Tue
CM 3.2.3 Describe water
purification on small scale and
water quality standard SGL (Batch
A to H)
PH1.11 Describe various
routes of drug
administration, eg., oral,
SC, IV, IM, SL
SGL (Batch A To H)
MI 1.1.7
Normal Microbial flora of
human body
SGL(Batch A to H)
MI 1.1.8 Culture
media and culture methods
SGL(Batch A to H)
--
03-03-21 Wed
PH1.3
Enumerate and identify drug
formulations and drug delivery
systems
Lecture
SU1.1 Describe Basic
concepts of homeostasis,
enumerate the metabolic
changes in injury and their
mediators.SU1.2 Describe
the factors that affect the
metabolic response to
injury
Lecture
--
04-03-21 Thu
PA 1.1
Describe the role of Pathologist in
diagnosis and management of
disease Lecture
MI 1.1.2 Introduction to
Parasitology,
classificattionand lab
diagnosis --Lecture
PA 1.2
Enumerate common terms
and definitions used in
Pathology Lecture
MI 1.1.10 Parasitological
agents-Peripheral Blood
Smear, Stool Concentration
Techniques, and Wet
Specimens
SGL(Batch A to H)
--
05-03-21 Fri
FM 2.1.1 to 2.2.1
Definition and Discription of death
and its types including somatic
molecular brain deatth , cortical
and brain stem death.
Lecture
PA 2.1
Cell injury and it's clinical
significance
Lecture--
PH4.1 Drug Administration using mannequins
DOAP (Batch A to H)
Clinical Posting Pharmacology
Community Medicine
PH 2.1- Demonstrate understanding of the use of
various dosage forms (oral/local/parenteral; solid/liquid)
DOAP (Batch A to H)
Clinical Posting
Clinical Posting
Clinical Posting
Microbiology Pathology Forensic Medicine
Date Day
Clinical Posting
Clinical Posting
Surgery
INTEGRAL INSTITUTE OF MEDICAL SCIENCES & RESEARCH, INTEGRAL UNIVERSITY, LUCKNOW
TIME TABLE - MBBS SECOND PROFESSIONAL (Session 2020-21)
06-03-21 Sat
IM25.1 Describe and discuss the
response and the influence of host
immune status, risk factors and
comorbidities on zoonotic
diseases
(e.g. Leptospirosis, Rabies) and
non-febrile infectious disease (e.g.
Tetanus)
AETCOM:
Module 2.1.1
The foundations
of communication 2 -
Introductory SGL
PA 2.2
Etiology, mechanism
and morphology of
reversible and
irreversible injury
SGL (Batch A to H)
PH1.4.1 - PH1.4.5
Describe absorption,
distribution,
metabolism &
excretion of drugs
Lecture
PA 2.4
Types and mechanism of
different forms of cell death
and autolysis
Lecture
MI 1.1.3
Introduction to Virology,
Classification & Diagnosis,
Bacteriophage
Lecture
PA 1.3
Describe history and
evolution of human
Pathology
SDL (Batch A to H)
Sports and Extra-curricular activities
07-03-21 Sun
08-03-21 Mon
FM 2.2.2 to 2.3
Nattural and Un-natural and
Sudden natural death
Lecture
FM 1.3.1 -1.3.2 , 1.4.1 &
1.4.2
CRPC, IPC, IEA, Inquest
Different Ofences and
Court and their Power
SGL
Sports and Extra-curricular activities
09-03-21 Tue
MI 1.1.5 Morphology
and Physiology of bacteria
Lecture
MI 1.1.12 Viral
Models, Rapid tests, ELISA
SGL (Batch A to H)--
10-03-21 Wed
PH 1.4.6-1.4.10 Describe
absorption, distribution,
metabolism & excretion of drugs
Lecture
MI 1.1.4
Introduction to Mycology
classification and lab
diagnosis
Lecture
PA 2.3
Intracellular accumulation
of fats, proteins,
carbohydrates and
pigments
SGL (Batch A to H)
MI 1.1.9
Biochemicals/Automation/M
olecular methods
SGL(Batch A to H)
--
11-03-21 Thu
12-03-21 Fri
PA 2.7
Mechanism of cellular aging and
apoptosis
Lecture
PH 1.4.11-1.4.15 Describe
absorption, distribution,
metabolism & excretion of
drugs
Lecture
PA 2.5
Pathologic calcification and
gangrene
SGL (Batch A to H)
PH1.5.1-PH 1.5.6 Describe
general principles of
mechanism of drug action
SGL(Batch A to H)
--
13-03-21 Sat OG 5.1.1 Describe, discuss and identify pre-existing medical disorders and discuss their management
MI 1.1.11
Mycology agents-
KOH mount, LCB
mount and SDA
SGL (Batch A to H)
MI 1.1.6
Bacterial genetics
Lecture
PA 2.6
Cellular adaptations -
Atrophy, hypertrophy,
hyperplasia, metaplasia
and dysplasia
Lecture
PH1.5.7-PH1.5.12 Describe
general principles of
mechanism of drug action
SGL(Batch A to H)
Sports and Extra-curricular activities
14-03-21 Sun
15-03-21 Mon
PA 3.1
Pathology of amyloidosis
Lecture
MI1.6.2 Methods of
Antimicrobial Susceptibility
Testing
SGL (Batch A to H)
FM 1.5.1 to FM 1.5.2
Summons, Conduct Money,
Witness SGL
PH1.5.13-PH1.5.18
Describe general principles
of mechanism of drug
action SGL(Batch A to H)
Sports and Extra-curricular activities
16-03-21 Tue
SU1.3 Describe basic concepts of
perioperative care.
Lecture
PH1.5.19-PH1.5.24
Describe general principles
of mechanism of drug
action
SGL(Batch A to H)
--
17-03-21 Wed
PH 1.4.16-1.4.20 Describe
absorption, distribution,
metabolism & excretion of drugs
Lecture
CM 3.2.2 Describe water
purification on large scale
SGL (Batch A to H)
MI1.4.1 Classify and
describe the different
methods of Sterilization
Lecture
PA 3.2
Demonstration of
amyloidosis in pathology
specimens
DOAP
--
Sunday
MI 1.2.1
Perform and Identify the different causative agents of
infectious diseases by Gram stain
DOAP (Batch A to H)
AETCOM Module 2.1.2
The foundations of communication 2 -
Focused small group session
Sunday
Clinical Posting
Clinical Posting
Clinical Posting
MI1.2.3 Perform and Identify the different causative
agents of infectious diseases by
Stool routine microscopy- Protozoa
DOAP (Batch A to H)
Maha Shiv Ratri
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
PA 2.8
Demonstration of manifestation and
consequences of various forms of cell
injuries in gross and microscopic specimens
DOAP (Batch A to H)
18-03-21 Thu
MI1.4.2 Classify and describe the
different methods of Disinfection
Lecture
PA 4.1
General features of acute
and chronic inflammation
including vascular and
cellular events
Lecture
VI - General Surgery
(nesting)
MI1.6.3 Discuss the
monitoring of antimicrobial
therapy -MIC/MBC
SGL (Batch A to H)
FM1.5.3 to 1.5.4
Recording of Evidence,
Oath, Affirmation,
Examinattion in-chief,
Cross and Re-examinations
SGL
--
19-03-21 Fri
PH1.5.25-PH1.5.26 Describe
general principles of mechanism
of drug action Lecture
PH1.16-Describe
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs which act by
modulating autacoids,
including: anti-histaminics,
5-HT modulating
drugs, NSAIDs, drugs for
gout, anti-rheumatic drugs,
drugs for
migraine. Histamine &
Antihistamincs SGL (Batch
A to H)
PA 4.3
Chronic inflammation - non-
specific and granulomatous
Lecture
MI1.4.3 - MI1.5.1 Choose
the appropriate methods of
Sterilization used in
laboratory, clinical and
surgical practice SGL
(Batch A to H)
VI General Surgery
(nesting)
--
20-03-21 Sat
PA 4.2
Chemical mediators of acute
inflammation
Lecture
VI - General Surgery (nesting)
AETCOM Module 2.1.3
Skill lab sessions Sports and Extra-curricular activities
21-03-21 Sun
22-03-21 Mon
PH 1.4.21-1.4.26 Describe
absorption, distribution,
metabolism & excretion of drugs
Lecture
PH1.16-
Describe mechanism/s of
action, types, doses, side
effects,
indications and
contraindications of the
drugs which act by
modulating autacoids,
including: anti-histaminics,
5-HT modulating
drugs, NSAIDs, drugs for
gout, anti-rheumatic drugs,
drugs for migraine.
Prostaglandins
SGL (Batch A to H)
PH1.16-
Describe mechanism/s of
action, types, doses, side
effects,
indications and
contraindications of the
drugs which act by
modulating autacoids,
including: anti-histaminics,
5-HT modulating
drugs, NSAIDs, drugs for
gout, anti-rheumatic drugs,
drugs for
migraine. NSAIDs (1)
SGL (Batch A to H)
MI1.4.4 - MI1.5.2 Choose
the appropriate methods of
Disinfection used in
laboratory, clinical and
surgical practice SGL
(Batch A to H)
VI General Surgery
(nesting)
Sports and Extra-curricular activitiesClinical Posting
Pandemic Module 2.1.1 to 2.1.4 Infection Conttrol:part-II Air borne precautions, contact precaution,infecttion control
committtee-4hours
Sunday
Clinical Posting
Clinical Posting
23-03-21 Tue
PA 5.1
Repair and regeneration including
wound healing
Lecture
VI - General Surgery (nesting)
PH1.16-Describe
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs which act by
modulating autacoids,
including: anti-histaminics,
5-HT modulating
drugs, NSAIDs, drugs for
gout, anti-rheumatic drugs,
drugs for
migraine. NSAIDs (2)
SGL (Batch A to H)
PA 4.4
Demonstration of acute and
chronic inflammation in
gross and microscopic
specimens
DOAP (Batch A to H)
AETCOM Module 2.1.4
Discussion and closure--
24-03-21 Wed
PA 6.3
Pathogenesis of shock and its
clinical stages
Lecture
VI - General Surgery (nesting)
PH1.16-
Describe mechanism/s of
action, types, doses, side
effects,
indications and
contraindications of the
drugs which act by
modulating autacoids,
including: anti-histaminics,
5-HT modulating
drugs, NSAIDs, drugs for
gout, anti-rheumatic drugs,
drugs for
migraine. 5HT and Migraine
Lecture
PA 6.1
Pathological aspects of
edema with clinical
correlation
Lecture
VI - General Medicine
(nesting)
MI1.3 Describe the
epidemiological basis of
common infectious
diseases -Bioterrorism
Lecture
HI Community Medicine
(nesting)
25-03-21 Thu
MI1.6.1 Describe the mechanisms
of Drug resistance
Lecture
HI Pharmacology (nesting)
PH1.13.1-PH1.13.6
Describe mechanism of
action, types, doses, side
effects,
indications and
contraindications of
adrenergic and anti-
adrenergic
drugs. Adrenergic System
SGL (Batch A to H)
PH1.13.7-PH1.13.18
Describe mechanism of
action, types, doses, side
effects,
indications and
contraindications of
adrenergic and anti-
adrenergic
drugs. Adrenergic System
SGL (Batch A to H)
IM15.12 Enumerate the indications for
whole blood, component and platelet
transfusion and describe the clinical
features and management of a
mismatched transfusion
--
26-03-21 Fri
PA 6.2
Pathological aspects of
hyperemia, congestion and
hemorrhage
Lecture
PH 1.25.1- PH1.25.6
Describe the mechanism/s
of action, types, doses,
side effects,
indications and
contraindications of the
drugs acting on blood, like
anticoagulants,
antiplatelets, fibrinolytics,
plasma expanders (1)
Lecture
VI - Phy/Gen.med
--
MI1.2.3 Perform and Identify the different causative
agents of infectious diseases by Stool routine
microscopy- Helminths
DOAP (Batch A to H)
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
27-03-21 Sat
OG5.1.2 Discuss evidence-based
intrapartum
care
PA 6.4
Normal haemostasis
and pathological
aspects of
thrombosis
Lecture
PH 1.25.7- PH1.25.12
Describe the
mechanism/s of
action, types, doses,
side effects,
indications and
contraindications of
the drugs acting on
blood, like
anticoagulants,
antiplatelets,
fibrinolytics, plasma
expanders ((2)
Lecture
VI - Phy/Gen.med
PH1.13.19-PH1.13.30
Describe mechanism
of action, types,
doses, side effects,
indications and
contraindications of
adrenergic and anti-
adrenergic
drugs. Anti
Adrenergic System
SGL (Batch A to H)
FM 1.5.5, 1.6.1 & 1.6.2
Conduct of Doctor in
Witness Box and Perjury
and Court Strictures
SGL
MI4.1.1 Anaerobes-
Clostridium perfringens
and other gas gangrene
causing Clostridium
Lecture
VI General Medicine
PA 6.5
Pathological aspects of
embolism
SGL
Sports and Extra-curricular activities
28-03-21 Sun
29-03-21 Mon
30-03-21 Tue
31-03-21 Wed
1.7.1 to 1.7.2
Discription and Differences about
Dying declaration and Dying
deposition
Lecture
PH1.13.31-PH1.13.33
Describe mechanism of
action, types, doses, side
effects,
indications and
contraindications of
adrenergic and anti-
adrenergic
drugs. Antti Adrenergic
System
SGL (Batch A to H)
PA 6.6
Pathological aspects of
ischaemia and infarction
along with its clinical
effects
SGL (Batch A to H)
PH 1.25.7- PH1.25.12
Describe the mechanism/s
of action, types, doses,
side effects,
indications and
contraindications of the
drugs acting on blood, like
anticoagulants,
antiplatelets, fibrinolytics,
plasma expanders.
Fibrinolytics (3)
Lecture VI - Phy/Gen.med
Sports and Extra-curricular activities
01-04-21 Thu
PA7.1
Neoplasia - Definition,
classification and general
characteristics
Lecture
PA 6.7
Demonstration of gross and
microscopic features of
infarction in a pathologic
specimen
DOAP (Batch A to H)
MI1.7.1 Antigen
Lecture
HI Pathology
PH1.13 Describe
mechanism of action,
types, doses, side effects,
indications and
contraindications of
adrenergic and anti-
adrenergic
drugs. SDL
--
02-04-21 Fri
03-04-21 Sat
PH1.6 Describe principles of
Pharmacovigilance & ADR
reporting systems
Lecture
MI4.1.3 Clostridium
difficileand non-
sporing anaerobes.
Lecture
VI General Medicine
PA 7.2
Molecular basis of
cancer
Lecture
FM 1.8.1 to 1.8.2
Latest decisions/
notification/ circulers
related to the
medicolegal practice
issued by the court.
SDL
SU3.1 Describe the
Indications and appropriate
use of blood and blood
products and complications
of blood transfusion.
Lecture
Sports and Extra-curricular activities
04-04-21 Sun
holi
Good Friday
AETCOM Module 2.2.1 Foundation
of bioethics Large
group session 1
Sunday
Clinical Posting
Clinical Posting
05-04-21 Mon
MI8.3 Describe the role of
Oncogenic viruses in the evolution
of virus associated malignancy
Lecture
VI General Medicine
HI Pathology
CM 3.2.3 Describe water
purification on small scale
and water quality standard
SGL (Batch A to H)
PH1.7 Define, identify and
describe the management
of adverse drug
reactions (ADR)
Lecture
IM 13.3 Describe the
relationship between
infection and cancers
Sports and Extra-curricular activities
06-04-21 Tue
PA 7.3
Discussion on the process of
carcinogenesis
Lecture
MI1.7.2 Antibody Lecture
HI Pathology
PA 7.4
Describe the effects of
tumor on the host including
para-neoplastic syndrome
SGL (Batch A to H)
FM 3.1.1 to 3.1.7
Identificaion Part-I
SGL
07-04-21 Wed
PH1.49 Describe mechanism of
action, classes, side effects,
indications
and contraindications of
anticancer drugs(1)
Lecture
MI1.8.2 Infecion
Lecture
VI Paediatrics
HI Pathology
PA 7.5
Immunology and immune
response to cancer
SGL
HI - Microbiology (sharing)
VI - Physiology (nesting)
PH1.49 Describe
mechanism of action,
classes, side effects,
indications
and contraindications of
anticancer drugs(3)
Lecture
--
08-04-21 Thu
MI1.8.3 Describe the host Immune
response
Lecture
VI Paediatrics
HI Pathology
PH1.49 Describe
mechanism of action,
classes, side effects,
indications
and contraindications of
anticancer drugs(2)
Lecture
PA 8.2
Exfoliative cytology -
Technique & stains used
SGL (Batch A to H)
VI - Surgery
PH 1.2.Describe the basis
of Evidence based
medicine and Therapeutic
drug monitoring
SGL(Batch A to H)
--
09-04-21 Fri OG 5.2 Determine maternal high risk factors and verify immunization status
PA 8.1
Diagnostic role of cytology
and its application in
clinical care
Lecture
VI - General Surgery
(nesting)
--
10-04-21 Sat
MI1.7.5 Complement system
Lecture
HI Pathology
CM 3.1 3.2 Describe
the health hazards of
water pollution and
describe the etiology
and basis of watter
borne diseases SGL
(Batch A to H)
MI 1.7.6 Structure
and function of
immune system
Lecture
HI Pathology
PH1.14.1 --1.14.4
Describe mechanism
of action, types,
doses, side effects,
indications and
contraindications of
cholinergic and
anticholinergic
drugs. Cholinergic
System
Lecture
MI1.8.1 Mechanism of
immunity
Lecture
VI Paediatrics
HI Pathology
Sports and Extra-curricular activities
11-04-21 Sun
12-04-21 Mon
PH1.14.5 --1.14.8 Describe
mechanism of action, types,
doses, side effects,
indications and contraindications
of cholinergic and anticholinergic
drugs. Cholinergic System
Lecture
PA 9.1
Principles and mechanisms
involved in immunity
SGL
HI - Micro (sharing)
VI - Pediatrics
MI1.10.1 Describe the
Immunological mechanism
in Hypersensitivity and the
lab methods used in
detection Lecture
VI Paediatrics
PA 9.2
Hypersensitivity reactions
and their mechanism
Lecture
HI - Micro (sharing)
Sports and Extra-curricular activities
PH3.4 To recognise and report an adverse drug
reaction
DOAP (Batch A to H)
PA 8.3
Demonstration of a cytology slide, its staining process
and its interpretation
DOAP (Batch A to H)
Sunday
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
13-04-21 Tue
PA 9.4
Autoimmunity and autoimmune
disorders
Lecture
SU4.2 Describe Clinical features,
Diagnose type and extent of
burns and
plan appropriate treatment.
SU4.3 Discuss the Medicolegal
aspects in burn injuries .FMT
nesting
Lecture
MI1.10.2 Describe the
Immunological mechanism
in Auto-immune disorders
and the lab methods used
in detection
Lecture
VI Paediatrics
Pandemic Module 2.2.1 exploratory and
interactive
theory session
( community medicine)
--
14-04-21 Wed
15-04-21 Thu
IM13.4 Describe the natural
history, presentation, course,
complications
and cause of death for common
cancers
PH1.50 Describe
mechanisms of action,
types, doses, side effects,
indications and
contraindications of
immunomodulators and
management of organ
transplant rejection
SGL (Batch A to H)
MI1.11 Describe the
Immunological mechanisms
of transplantation and
tumour immunity
Lecture
PA 9.3
HLA system and immune
principles involved in organ
transplantation
Lecture
HI - Micro (sharing)
--
16-04-21 Fri
MI 2.7.1 Describe the
epidemiology, etiology, evolution,
complication and opportunistic
infecions in case of HIV Lecture
HI Pathology
VI General Medicine
FM 3.1.8 to 3.1.10 and 3.2.1
to 3.2.2
Identificaion Part-II and
Identificaion Part-III
SGL
PA 9.6
Pathogenesis and
pathology of HIV and AIDS
Lecture
HI - Micro (sharing)
VI - Medicine (nesting)
PH1.48.16 to 1.48.20
Describe the mechanisms
of action, types, doses,
side effects,
indications and
contraindications of the
drugs used in UTI/ STD
and viral diseases including
HIV. Anti HIV drugs(1)
Lecture
--
17-04-21 Sat
OG 12.7 Describe and discuss
screening, risk factors,
management of
mother and newborn with HIV
MI2.7.2 Discuss the
lab diagnosis,
prevention and
principle of
management of HIV
SGL (Batch A to H)
HI Pathology
VI General Medicine
CM 7.2.1 & 8.1.1 AIDS-
Epidemiology, Prevention
and Conrol
Lectture
VI General Medicine
MI1.7.3 Antigen - Antibody
reaction 1 Lecture
HI Pathology
PA 9.5
Define and describe the
pathogenesis of systemic
Lupus Erythematosus
SGL (Batch A to H)
VI - Medicine
Sports and Extra-curricular activities
18-04-21 Sun
19-04-21 Mon
MI 1.7.4 Antigen - antibody
reaction 2 Lecture
HI Pathology
SU5.1 Describe normal wound healing
and factors affecting healing.
SU5.3 Differentiate the various types of
wounds, plan and observe
management of wounds
SU5.4 Discuss medico legal aspects of
wounds
Lecture
PH1.48.16 to 1.48.20
Describe the mechanisms
of action, types, doses,
side effects,
indications and
contraindications of the
drugs used in UTI/ STD
and viral diseases including
HIV. Anti HIV drugs(2)
Lecture
PH1.14 Describe
mechanism of action,
types, doses, side effects,
indications and
contraindications of
cholinergic and
anticholinergic
drugs. SDL
Sports and Extra-curricular activities
Ambedkar Jayanti
PH1.14.9 --1.14.25 Describe mechanism of
action, types, doses, side effects,
indications and contraindications of
cholinergic and anticholinergic
drugs. Anti cholinergic SGL (Batch A- D)
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Sunday
20-04-21 Tue
PH1.10 Describe parts of a
correct, complete and legible
generic
prescription. Identify errors in
prescription and correct
appropriately. Lecture
MI2.5.3 Describe the
etiology and clinical
evolution of Malaria
Lecture
HI Pathology (sharing)
VI - General Medicine
(nesting)
--
21-04-21 Wed
22-04-21 Thu
PA 9.7
Pathogenesis of common auto-
immune disorders Lecture
VI - Medicine
PA 10.1
Pathological aspects of
malaria
SGL
HI - Micro (sharing)
VI - Medicine (nesting)
MI2.5.4 Discuss the lab
diagnosis of Malaria
SGL (Batch A to H)
HI Pathology
VI - General Medicine
(nesting)
PH1.47.1-PH1.47.4
Describe the mechanisms
of action, types, doses,
side effects,
indications and
contraindications of the
drugs used in malaria,
KALA-AZAR, amebiasis and
intestinal helminthiasis.
Antimalarial drugs (1) SGL
(Batch A to H) VI-Gen.Med.
--
23-04-21 Fri
IM 25. 2 Discuss and describe the
common causes, pathophysiology
and
manifestations of these diseases
MI1.10.3 Describe the
Immunological mechanism
in Immunodeficiency states
and the lab methods used
in detection
Lecture
VI Paediatrics
PH1.47.5-PH1.47.9
Describe the mechanisms
of action, types, doses,
side effects,
indications and
contraindications of the
drugs used in malaria,
KALA-AZAR, amebiasis and
intestinal helminthiasis.
Antimalarial drugs (2) SGL
(Batch A to H) VI-Gen.Med.
AETCOM FM 4.1 and 4.2
Medical Ethics and its
historical emergance.
Lecure
--
24-04-21 Sat
PA 13.1
Hematopoiesis and
extramedullary hematopoiesis
SDL
Sports and Extra-curricular activities
25-04-21 Sun
26-04-21 Mon
PH1.52 Describe management of
common poisoning, insecticides,
common sting and bites
Lecture
VI-Gen.Med.
PA 11.2
Pathology of tumor and
tumour like conditions of
infancy and childhood
SGL (Batch A to H)
VI - Pediatrics (nesting)
PA 11.3
Pathology of common
storage disorders of
infancy and childhood
SGL (Batch A to H)
VI - Pediatrics (nesting)
MI8.1.3 Zoonotic disease -
Anthrax
SGL (Batch A to H)
VI General Medicine
Sports and Extra-curricular activities
27-04-21 Tue
PA 11.1
Common cytogenetic and
mutational disorders of childhood
Lecture
VI - Pediatrics (nesting)
MI 1.9 Discuss the
Immunological basis of
vaccines and describe the
universal immunisation
schedule
Lecture
VI - Paediatrics (nesting)
--
Ram navami
MI2.6.1 Identify causative agents of malaria
DOAP (Batch A to H)
VI-General Medicine
AETCOM Module 2.2.2
Foundation of bioethics
Large group session 2
Pathology Formative Assessment Test
1
Sunday
Formative Assessment -1
Pharmacology
Clinical Posting
Clinical Posting
Clinical Posting
Pandemic Module 2.2.2 small group asignment emerging and reemerging
infectious disease
( community medicine)
Clinical Posting
Clinical Posting
28-04-21 Wed
OG 10.2 Enumerate the
indications and describe the
appropriate use of
blood and blood products, their
complications and management VI
PATHOLOGY
MI8.8.1 Describe the
mehods used and
significance of assessing
the Microbial contamination
of food SGL
(Batch A to H)
PA 12.1
Pathology of disorders
caused by air pollution,
tobacco and alcohol
SGL
HI - Community Medicine
(Nestiing)
CM 3.4.1 concept of Solid
waste and
its management LECTURE
--
29-04-21 Thu
PH1.15 Describe mechanism/s of
action, types, doses, side effects,
indications and contraindications
of skeletal muscle relaxants
Lecture
VI Anaes,Phy
SU7.1 Describe the
Planning and conduct of
Surgical audit
Lecture
MI8.8.2 Describe the
mehods used and
significance of assessing
the Microbial contamination
of water
SGL (Batch A to H)
CM 8.3.1 NACP
Lecture
VI-GENERAL MEDICINE,
PEDIATRICS
--
30-04-21 Fri
AETCOM FM 4.3 & 4.4
MCI & SMCI function and role and
indian medical register.
SGL
IM 15. 11 Develop, document and
present a treatment plan that includes
fluid
resuscitation, blood and blood
component transfusion, and specific
therapy for arresting blood loss
Sports and Extra-curricular activities
01-05-21 Sat
CM 2.5 Describe
poverty and social
security measures
and its relationship
to health and disease
SDL
PH 5.1Communicate with the
patient with empathy and
ethics on all
aspects of drug use SGL
PH 5.7 Demonstrate an understanding
of the legal and ethical aspects of
prescribing drugs SGL
PH 5.5 Demonstrate an understanding
of the caution in prescribing drugs
likely to produce dependence and
recommend the line of
management.
SGL (Batch A-D)
VI-Psychiatry.
02-05-21 Sun
03-05-21 Mon
PH1.59 Describe and discuss the
following: Essential medicines,
Fixed
dose combinations, Over the
counter drugs, Herbal medicines
Lecture
CM 7.2.2 & 8.1.2 Malaria
epidemiology, prevention,
conttrol, treatment
SGL (Batch A to H)
VI General Medicine
PA 12.2
Pathology of protein calorie
malnutrition and starvation
SGL (Batch A to H)
VI - Biochemistry,
Pediatric, Community
Medicine (nesting)
PH3.7 Prepare a list of
essential medicines for a
healthcare facility DOAP
(Batch A to H)
Sports and Extra-curricular activities
04-05-21 Tue
MI 8.1.1 Zoonotic diseases -
Plague Lecture VI
General Medicine
Formative Assessment
PA 12.3
Pathogenesis of obesity
and its consequences
SGL (Batch A to H)
VI - Medicine (nesting)
PH1.61 Nutraceutical
SGL(Batch A to H)--
05-05-21 Wed
PA 22.1
Classification and description of
blood group systems
Lecture
MI8.1.2 Rickettsia Lecture
VI General Medicine
PA 22.2
Blood compatibility testing -
Principles, indications and
steps involved.
SGL (Batch A to H)
VI - Obs Gyn (nesting)
Pathology Formative
assesment 1
Feedback
--
06-05-21 Thu
OG 8.1 Enumerate, describe and
discuss the objectives of antenatal
care,
assessment of period of gestation;
screening for high-risk factors. VI
Community medicine
CM 10.5 UIP SGL
PA 22.5
Blood transfusion reactions
and its lab investigation
SGL (Batch A to H)
VI - Medicine (nesting)
Microbiology
formative
assessment -1
feedback
--
07-05-21 Fri Jamat-ul-Wida
Clinical Posting
Clinical Posting
Sunday
Microbiology Formative Assesment-1
PH 4.2 Demonstrate the effects of drugs on blood
pressure (vasopressor
and vaso-depressors with appropriate blockers) using
computer
aided learning. (1) DOAP (Batch A to H)
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
PA 34.4
Identify, distinguish and describe
common tumors of the skin DOAP
08-05-21 Sat
PA 22.3
Blood components and their
clinical use Lecture
VI - Surgery, Medicine (nesting)
Pharmacology
Formative
Assessment-1
Feed back
MI 8.1.4
Zoonotic diseases-
Tularemia, KFD, Prions
SGL(Batch A to H)
VI General Medicine
Sports and Extra-curricular activities
09-05-21 Sun
10-05-21 Mon
PH1.17 Describe the mechanism/s
of action, types, doses, side
effects,
indications and contraindications
of local anesthetics.
Lecture
VI-Anes.
PA 22.4
Infections transmitted by
blood transfusion
SGL (Batch A to H)
HI - Microbiology (sharing)
MI 3.1.3
Enumerate and describe
the epidemiology,
pathogenesis and clinical
feature of microbial agents
causing Dysentery Lecture
VI General Medicine and
Paediatrics HI
Pathology (Sharing)
PH1.47 Describe the
mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in malaria, Kala
azar, amebiasis and
intestinal helminthiasis.
Anti Amoebic drugs
SGL (Batch A to H)
Sports and Extra-curricular activities
11-05-21 Tue
MI 8.16 Describe the
National health programs in the
prevention of common infectious
diseases Lecture
HI Community Medicine
CM 3.1.1 Describe the
source, monitoring and
healh hazards of air
pollution
SGL (Batch A to H)
VI-GENERAL MEDICINE,
ENT
PA 22.6 Indications,
principle and procedure of
autologous blood
transfusion
SGL (Batch A to H)
PH1.55.1 - PH1.55.7
Describe and discuss the
following National Health
Programmes
including Immunisation,
Tuberculosis, Leprosy,
Malaria, HIV, Filaria, Kala
Azar, Diarrhoeal diseases,
Anaemia & nutritional
disorders, Blindness, Non-
communicable diseases,
cancer and Iodine
deficiency. SDL
--
12-05-21 Wed
PA 23.2
Body fluid analysis and abnormal
findings in various disease states
Lecture
MI 3.1.4
Discuss the diagnostic
modalities of microbial
agents causing Dysentery
SGL (Batch A to H)
VI General Medicine and
Paediatrics HI
Pathology (Sharing)
--
13-05-21 Thu
SU7.2 Describe the principles and
steps of clinical research in
General
Surgery
Lecture
CM 3.4.2 human Excreta
and sewage disposal
SGL (Batch A to H)
PA 24.1
Pathological aspects and
clinical features of oral
cancers
SGL (Batch A to H)
VI - Dentistry (nesting)
PH1.55.8- PH1.55.12
Describe and discuss the
following National Health
Programmes
including Immunisation,
Tuberculosis, Leprosy,
Malaria, HIV, Filaria, Kala
Azar, Diarrhoeal diseases,
Anaemia & nutritional
disorders, Blindness, Non-
communicable diseases,
cancer and Iodine
deficiency.
SDL
--
14-05-21 Fri
15-05-21 Sat
16-05-21 Sun
Clinical Posting
Sunday
PA 23.1
Abnormal urinary findings in various disease states.
Identification of common urinary abnormalities in a
clinical specimen
DOAP
PH2.4 Demonstrate the correct method of calculation of
drug dosage in patients including those used in special
situations DOAP
(Batch A to H)
AETCOM Module 2.3
Health care as a right
Participatory student seminar
Clinical Posting
Clinical Posting
Clinical Posting
IDUL FITR
17-05-21 Mon
PA 24.2 and 24.3
Pathological aspects of peptic
ulcer disease
Lecture
VI - Medicine (nesting)
MI 3.6.1
Describe the etiology of
Acid Peptic Disease (APD)
and the clinical course.
Lecture VI
General Medicine
HI Pathology (Sharing) and
Pharmacology
Sports and Extra-curricular activities
18-05-21 Tue
IM 15.15 Describe and enumerate
the indications, pharmacology and
side
effects of pharmacotherapy of
acid peptic disease including
Helicobacter pylori
PH1.34.Describe the
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs used as below:
1. Acid-peptic disease and
GERD
2. Antiemetics and
prokinetics
3. Antidiarrhoeals
4 . Laxatives
5. Inflammatory Bowel
Disease
6. Irritable Bowel
Disorders, biliary and
pancreatic diseases. Drugs
for APD (1)Lecture VI
Gen.Med.
--
19-05-21 Wed
AETCOM FM 4.10 & 4.29
Communicaion between Doctor,
Public and Media
Lecture
--
20-05-21 Thu
CM 19.1 & 19.2 Define and
describe the concept of essenttial
medicine list and its role in
primary health care HI-
Pharmacology (sharing) SGL
(Batch A to H)
PH1.34.Describe the
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs used as below:
1. Acid-peptic disease and
GERD
2. Antiemetics and
prokinetics
3. Antidiarrhoeals
4 . Laxatives
5. Inflammatory Bowel
Disease
6. Irritable Bowel
Disorders, biliary and
pancreatic diseases. Drugs
for APD (2)
Lecture
VI Gen.Med.
MI 3.6.2
Discuss the diagnosis and
management of causative
agent of APD. SGL
(Batch A to H) VI
General Medicine
HI Pathology (Sharing) and
Pharmacology
PA 24.4
Pathological aspects of
carcinoma of stomach
Lecture
VI - Surgery (nesting)
--
MI 3.2.4 Identify
the common etiologic agent of dysentery- Shigella
DOAP (Batch A to H) VI
General Medicine and Paediatrics
Formative assesment Pathology 2
Clinical Posting
Clinical Posting
Clinical Posting
Clinical PostingPandemic Module 2.2.3 and 2.2.4
SGD plenary session
21-05-21 Fri
MI 3.1.1 Enumerate
and describe the epidemiology,
pathogenesis and clinical feature
of microbial agents causing
Diarrhoea Lecture
VI General Medicine and
Paediatrics HI
Pathology (Sharing)
PH1.34.Describe the
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs used as below:
1. Acid-peptic disease and
GERD
2. Antiemetics and
prokinetics
3. Antidiarrhoeals
4 . Laxatives
5. Inflammatory Bowel
Disease
6. Irritable Bowel
Disorders, biliary and
pancreatic diseases.
Anidiarrhoeals
Lecture
VI Gen.Med.
PA 24.5
Pathologic features of
tuberculosis of the
intestine
SGL (Batch A to H)
VI - Surgery (nesting)
FM 2.5.1 , 2.5.2, 2.6.1,
2.7.1, 2.7.2
Moment and modes of
deaths, Asphyxia and
syncope.&
Presumptions of death and
survivership. Suspended
animation
SGL
--
22-05-21 Sat
PA 24.7
Describe the etiology,
pathogenesis, pathology and
distinguishing features of
carcinoma of the colon
Lecture
VI - Surgery (nesting)
PH1.34.Describe the
mechanism/s of
action, types, doses,
side effects,
indications and
contraindications of
the drugs used as
below:
1. Acid-peptic
disease and GERD
2. Antiemetics and
prokinetics
3. Antidiarrhoeals
4 . Laxatives
5. Inflammatory
Bowel Disease
6. Irritable Bowel
Disorders, biliary and
pancreatic diseases.
Drugs for
Inflammatory bowel
disease
SGL (Batch A to H)
PA 24.6.1 to PA
24.6.4
Pathological aspects
and distinguishing
features of
inflammatory bowel
disease
SGL (Batch A to H)
VI - Surgery (nesting)
MI 3.1.2
Discuss the
diagnostic modalities
of microbial agents
causing Diarrhoea
SGL (Batch A to H)
VI General Medicine
and Paediatrics
HI Pathology
(Sharing)
PA 24.6.5 to PA 24.6.8
Pathological aspects and
distinguishing features of
inflammatory bowel
disease SGL
(Batch A to H)
VI - Surgery (nesting)
Sports and Extra-curricular activities
23-05-21 Sun
24-05-21 Mon
25-05-21 Tue
26-05-21 Wed
27-05-21 Thu
28-05-21 Fri
29-05-21 Sat
30-05-21 Sun
31-05-21 Mon
01-06-21 Tue
AITO
Jaundice 02
/06/2021
Wed
PA 25.1.1 to PA 25.1.3
Bilirubin metabolism.
Pathogenesis and types of
jaundice
Lecture
PA 25.1.4 to PA 25.1.6
Aetiological causes and lab
tests used for
distinguishing different
types of jaundice
SGL (Batch A to H)
PA 25.3.1 to PA 25.1.4
Viral and toxic hepatitis -
Pathology,complications
and consequences.
Lecture
VI - Medicine (nesting)
OG 12.6. 1Describe the
clinical features, detection,
effect of pregnancy on the
disease and impact of the
disease on pregnancy HI
MEDICIE
Sports and Extra-curricular activities
Ist Terminal
1st Terminal
Budh Poornima
1st Terminal
MI 3.2.1
Identify the common etiologic agent of Diarrhea -Vibrio
cholerae
DOAP (Batch A to H) VI
General Medicine and Paediatrics
1 st Terminal Communiy Medicine theory
Sunday
Sunday
Clinical Posting
03-06-21 Thu
MI 3.7.1 Describe
the epidemiology of viral hepatitis
Lecture VI
General Medicine
HI Pathology (Sharing)
PH 1.48 Describe the
mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in UTI/ STD
and viral diseases including
HIV. Drugs for hepatitis
Lecture
HI-Microbiology
PA 25.3.5 to PA 25.3.9
Viral and toxic hepatitis -
Pathology,complications
and consequences.
SGL
VI - Medicine (nesting)
SU3.1 Describe the
Indications and appropriate
use of blood and blood
products and complications
of blood transfusion.
Lecture
--
04-06-21 Fri
IM 5.4 Describe and discuss the
epidemiology , microbiology
immunology
and clinical evolution of infective
(viral) hepatitis
PE 20.19 Neonatal hyperbilirubinemia
Lecture--
05-06-21 Sat
OG 12.6.2 complications and
management of liver disease in
pregnancy HI MEDICIE
SU28.12 Describe the
applied anatomy of biliary
system. Describe the
clinical features,
investigations and
principles of management
of
diseases of biliary system
Lecture
Sports and Extra-curricular activities
06-06-21 Sun
07-06-21 Mon
PA 25.2 Hepatic
failure Lecture
VI - Medicine, Surgery
PA 25.5
Pathological aspects of
portal hypertension
SGL
VI - Medicine, Surgery
(nesting)
CM 3.6 National vector
borne disease control
programme
SGL (Batch A to H)
VI-MICROBIOLOGY
PA 25.4.1 o PA 25.4.4
Alcoholic liver disease
including cirrhosis
SGL
VI -- Medicine, surgery
Sports and Extra-curricular activities
08-06-21 Tue
FM 1.10 to 1.11
Cause of death in particular
scenario and cause of death
certificate by refering ICD-10
Code.
Lecture
PA 25.4.5 to PA 25.4.8
Alcoholic liver disease
including cirrhosis
SGL
VI -- Medicine, surgery
--
09-06-21 Wed
PA 32.1
Thyroid swellings - Classification,
etiology, pathogenesis and
pathology
Lecture
VI - Anatomy, Physiology,
Medicine, Surgery (nesting)
FM 2.8.1 to 2.8.2
Postmortem changes
includings sighns of death,
postmortem lividity RM
SGL
.
--
10-06-21 Thu
IM 12.2 Describe and discuss the
genetic basis of some forms of
thyroid
dysfunction
MI 3.3.1
Describe the Enteric fever
pathogen and the clinical
course of the disease
Lecture VI
General Medicine
HI Pathology (Sharing) and
Pharmacology
--
1 st Terminal Communiy Medicine theory
Pathology
Formative assessment test 3
Sunday
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
PH 3.1 Write a rational, correct and legible generic
prescription for a given condition and communicate the
same to the patient for hepatitis (1).
DOAP (Batch A to H)
1 st Terminal Communiy Medicine practical
PA 25.6
Interpret liver function test report and viral hepatitis
serology panel.
DOAP (Batch A to H)
VI - Medicine (nesting)
PH4.2 Demonstrate the effects of drugs on blood
pressure (vasopressor and vaso-depressors with
appropriate blockers) using computer aided learning.
Rabbit eye CAL DOAP (Batch A to H)
Aetcom Module 2.4.1
Working as a health care team
Tag along session 1
11-06-21 Fri
PA 32.2
Thyrotoxicosis - Pathological
aspects, laboratory and imaging
features. Lecture
VI - Physiology and Medicine
(nesting)
MI 3.3.2
Discuss the lab diagnosis
of Enteric fever
SGL (Batch A to H) VI
General Medicine
HI Pathology (Sharing) and
Pharmacology
PH1.42- Describe general
principles of Antimicrobial
chemotherapy.
Drugs for enteric fever
Lecture
HI-Micro ((Sharing)
Pandemic Module 2.3.1
describe specimen
selection collection
,transport,storage
required during
pandemic- Lecture
--
12-06-21 Sat
MI 3.5.1
Enumerate the
caustive agents of
Food poisoniong and
their clinical course
Lecture
VI General Medicine
HI Pharmacology
PA 32.3
Hypothyroidism -
Pathological aspects,
laboratory and
imaging features
SGL
VI - Physiology and
Medicine (nesting)
HI - Pharmacology
(sharing)
PH1.36.3 Describe the
mechanism of action,
types, doses, side effects,
indications and
contraindications of drugs
used in endocrine
disorders (diabetes
mellitus, thyroid disorders
and osteoporosis) Drugs
for Thyroid disorders (1)
Lecture
VI Gen.Med. (Nesting)
HI-Pathology((Sharing)
Sports and Extra-curricular activities
13-06-21 Sun
14-06-21 Mon
PH1.36.3 Describe the mechanism
of action, types, doses, side
effects,
indications and contraindications
of drugs used in endocrine
disorders (diabetes mellitus,
thyroid disorders and
osteoporosis) Drugs for Thyroid
disorders (2)
Lecture
VI Gen.Med. (Nesting)
HI--Pathology((Sharing)
CM 12.1 & 12.2 Define and
describe the concept of
geriaric services along with
their health problems
LECTURE
MI 3.5.2
Discuss the lab diagnosis
of Food poisoning
SGL (Batch A to H)
VI General Medicine
HI Pharmacology
PA 32.5
Hyperparathyroidism -
Pathological aspects and
laoratory features
SGL
VI - Physiology, Medicine
(nesting)
Sports and Extra-curricular activities
15-06-21 Tue
PA 32.8
Cushing's syndrome - Pathological
aspects and laboratory features
Lecture
VI -Physiology, Medicine (nesting)
PA 32.7
Adrenal insufficiency -
Pathological aspects and
laboratory features
SGL
VI -Physiology, Medicine
(nesting)
--
16-06-21 Wed
PH1.38.1 Describe the mechanism
of action, types, doses, side
effects,
indications and contraindications
of corticosteroids.
Lecture
OG 8.2 Elicit document and present an
obstetric history including menstrual
history, last menstrual period, previous
obstetric history, comorbid
conditions, past medical history and
surgical history
--
Aetcom Module 2.4.2
Working as a health care team
Tag along session 2
PH3.5 To prepare and explain a list of P-drugs for a
given case/condition (1) DOAP (Batch A to H)
MI 3.4.1
Identify the different modalities for diagnosis of Enteric
fever in early disease-blood culture and widal
DOAP (Batch A to H)
VI General Medicine
HI Pathology
Sunday
Clinical Posting
Clinical Posting
Clinical Posting
MI 3.4.2 Identify the different
modalities for diagnosis of Enteric fever in late disease-
stool culture and urine culture
DOAP (Batch A to H)
VI General Medicine
HI Pathology
Clinical Posting
17-06-21 Thu
PA32.9
Adrenal neoplasms - Pathological
aspects and laboratory features
Lecture
VI - Anantomy, Physiology,
Medicine, Surgery
SU23.1 Describe the applied
anatomy of adrenal glands
SU23.2 Describe the
etiology, clinical features
and principles of
management of disorders of
adrenal gland
Lecture
--
18-06-21 Fri
IM 16.3 Describe and discuss the
chronic effects of diarrhea
including
malabsorption
PH1.38.1 Describe the
mechanism of action,
types, doses, side effects,
indications and
contraindications of
corticosteroids. Lecture
--
19-06-21 Sat
PH1.38.1 Describe
the mechanism of
action, types, doses,
side effects,
indications and
contraindications of
corticosteroids.
Lecture
PA 27.1.1 to 27.1.6
Various forms of
arteriosclerosis and
their pathological
aspects
SGL
VI -- Medicine
(nesting)
MI8.9.3 Discuss the method
of Collecion of sample -
Stool SGL(Batch A to H)
PH 1.42.1 o PH.42.6
General principles of
Antimicrobial
chemotherapy SGL (Batch
A to H)
FM 2.8.3 to 2.8.7
Diffferentiate PM stanning
witth Bruise and
congestion Rigermortis and
its medicolegal importance
in estimating TSD. SGL
Sports and Extra-curricular activities
20-06-21 Sun
21-06-21 Mon
PA 27.2
Aortic aneurysms -etiology,
dynamics and pathology
Lecture
VI - Medicine (nesting)
PA27.1.7 to PA27.1.11
Various forms of
arteriosclerosis and their
pathological aspects
SGL
VI -- Medicine (nesting)
PH 1.42.7- PH.42.11
General principles of
Antimicrobial
chemotherapy SGL (Batch
A to H)
AETCOM Module 2.5.1
Bioethics continued – Case
studies on patient
autonomy and decision
making.
Introduction and group
formation
Sports and Extra-curricular activities
22-06-21 Tue
MI2.1.1 Describe the Etiological
agent in rheumatic fever Lecture
VI - Gen Mediciene HI- Patthology
(sharing)
PH 1.24 Describe the
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs affecting renal
systems including
diuretics, antidiuretics-
vasopressin and
analogues. Diuretics (1)
Lecture
--
23-06-21 Wed
OG 8.7 Enumerate the indications
for and types of vaccination in
pregnancy
CM 12.3 & 12.4 prevention
of health problems of aged
ppopulattion and national
program for elderly.
LECTURE
PH 1.24 Describe the
mechanism/s of action,
types, doses, side
effects,indications and
contraindications of the
drugs affecting renal
systems including
diuretics, antidiuretics-
vasopressin and
analogues. Diuretics (2)
SGL (Batch A to H)
MI2.2.1 Describe
theEtiological agents and
clinical features of Inf
Enocarditis Lecture VI -
Gen Mediciene HI-
Patthology (sharing)
--
Clinical Posting
Clinical Posting
Aetcom Module 2.4.3
Working as a health care team
Small group discussion
MI3.4.
MI3.2.5 Identify the common etiologyical agent of
dysentry -Entamoeba histolytica DOAP (Batch A to
H) VI General Medicine and Paediatrics
MI2.3 Identtify the microbial agentts causing Rheumatic
heart disease Streptococcus and enterococcus
DOAP(Batch A to H) VI - Gen Mediciene HI-
Patthology (sharing)
Clinical Posting
Clinical Posting
Clinical Posting
Sunday
24-06-21 Thu
PA 27.3
Heart failure - Pathological
aspects and complications
Lecture
VI - Medicine, Physiology
(nesting)
PA 27.4
Rheumatic fever -
Pathological aspects and
complications
Lecture
VI - Gen Mediciene
(nesting)
HI - Microbiology (sharing)
MI 2.1.2 Discuss the lab
diagnosis of Rheumatic
fever - SGL (Batch A
to H) VI - Gen
Mediciene HI- Patthology
(sharing)
PH 1.24 Describe the
mechanism/s of action,
types, doses, side
effects,indications and
contraindications of the
drugs affecting renal
systems including
diuretics, antidiuretics-
vasopressin and
analogues. Antidiuretics
SGL(Batch A to H)
--
25-06-21 Fri
SU23.3 Describe the clinical
features, principles of investigation
and
management of Adrenal tumors
Lecture
PA 27.6
Infective endocarditis -
Pathological aspects and
complications
Lecture
HI - Microbiology (sharing)
VI - Medicine (nesting)
MI2.2.2Discuss the lab
diagnosis of Infecive
endocarditis SGL (Batch A
to H) VI - Gen
Mediciene HI- Patthology
(sharing)
Pathology
formative
assesment 2
Feedback
--
26-06-21 Sat
PH1.26 Describe mechanisms of
action, types, doses, side effects,
indications and contraindications
of the drugs modulating the
reninangiotensin
and aldosterone system.(1)
Lecture
VI Phy., Gen. Med.(Nesting)
PA 27.7
Pericardial effusion -
Pathological aspects
and complications
SGL
VI - Medicine
(nesting)
PA 27.4 and PA 27.6
Rheumatic fever and
endocarditis
SGL
Sports and Extra-curricular activities
27-06-21 Sun
AITO CAD Mon
IM 2.4 Discuss and describe the
pathogenesis natural history,
evolution
and complications of
atherosclerosis and IHD
PA 27.5.1 to PA 27.5.5
Pathology of coronary artey
disease Lecture
VI - Medicine
OG 12.4.1 Define, classify
and describe the etiology,
pathophysiology,
diagnosis, investigations,
criteria of heart diseases in
pregnancy HI MEDICINE
SU22.1 Describe the applied
anatomy and physiology of
thyroid
SU22.2 Describe the
etiopathogenesis of
thyroidal swellings
Lecture
Sports and Extra-curricular activities
29-06-21 Tue
PA 27.5.6 to PA 27.5.10
Pathology of coronary artery
disease
Lecture VI -
Medicine
PH1.28.1 -- 1.28.4 Describe
the mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in
ischemic heart disease
(stable, unstable angina
and myocardial
infarction), peripheral
vascular disease (2) Lecure
VI Gen. Med.
PA 27.5.8 and PA 27.8.2
Lab diagnosis of coronary
artey disease
SGL
VI -- Physiology, Medicine
(nesting)
IM 2.5 Define the various
acute coronary syndromes
and describe their
evolution, natural history
and outcomesmedikine
--
Clinical Posting
Clinical Posting
FM 2.9.1 to 2.10.2 DOAP
Discribe putrefaction Mummification, Adipocere and
Maceration.Its MLI.
Discuss TSD.
Pharmacology Formative
Assessment -2
Clinical Posting
Clinical Posting
Sunday
30-06-21 Wed
OG 12.4.2 Describe adverse
effects on the mother and
foetus and the management during
pregnancy and labor, and
complications of heart diseases in
pregnancy HI MEDICINE
CM 8.2.1 & 7.2.5
Describe and discuss the
epidemiology, conrol
measures including lab
ttestt at primary care level
for CAD
LECTURE
VI Gen Med.
--
01-07-21 Thu
SU22.4 SU22.5 & SU22.6 Describe
the clinical features, classification
and principles of
management of thyroid cancer
Describe the applied anatomy of
parathyroid
Describe and discuss the clinical
features of hypo - and
hyperparathyroidism and the
principles of their management
Lecture
PH1.28.5 -- 1.28.9 Describe
the mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in
ischemic heart disease
(stable, unstable angina
and myocardial
infarction), peripheral
vascular disease (2) Lecure
VI Gen. Med.
CM 8.2.2 & 7.2.6
Describe and discuss the
epidemiology, conrol
measures including lab test
at primary care level for
Hypertension
LECTURE
VI Gen Med.
IM 2.15 Discuss and
describe the medications
used in patients with an
acute coronary syndrome
based on the clinical
presentation
--
02-07-21 Fri
OG 12.1.1 Define, classify and
describe the etiology and
pathophysiology,
early detection, investigations;
of eclampsia.
OP 8.1 Discuss clinical feautres and
management of vascualar occlusions of
retina
LECTURE (ophthalmology)
--
03-07-21 Sat
AETCOM Module 2.5.2
Bioethics continued – Case
studies on patient autonomy and
decision making.
Case introduction
Sports and Extra-curricular activities
04-07-21 Sun
05-07-21 Mon
PH1.26 Describe mechanisms of
action, types, doses, side effects,
indications and contraindications
of the drugs modulating the
reninangiotensin
and aldosterone system. (2)
Lecture
VI Phy,Gen.Med.(Nesting)
CM 7.2.4 & 8.1.4 Describe
the epidemiology,
mode of transmission and
measures
for preventtion
and control of
Viral hepatittis LECTURE
VI General Medicine
Sports and Extra-curricular activities
06-07-21 Tue
PH1.27 Describe the mechanisms
of action, types, doses, side
effects,
indications and contraindications
of antihypertensive drugs and
drugs used in shock. (1)
Lecture
VI Gen.Med.(Nesting)
PH1.27 Describe the
mechanisms of action,
types, doses, side effects,
indications and
contraindications of
antihypertensive drugs and
drugs used in shock. (2)
Lecture
VI Gen.Med.
--
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
FM 2.11.1 to 2.11.4 DOAP
Describe and discuss autopsy procdures including
postmortem examination. Different types of
autopsies.Aims and Objectives of postmortem
examinations and Dissection and removal various organ
during autopsy.
Sunday
PA 27.8
Interpret abnormalities in cardiac function testing in
acute coronary syndromes
DOAP (Batch A to H)
VI - Physiology, Medicine (nesting)
PH 3.1 Write a rational, correct and legible generic
prescription for a given condition and communicate the
same to the patient for CAD (2)
DOAP (Batch A to H)
AETCOM Module 2.5.3
Bioethics continued – Case studies on patient autonomy
and decision making.
Self-directed learning
Pandemic Module 2.3.2 to 2.3.4 sample collection, lab visit, group activity
MICROBIOLOGY
PH3.3-Perform a critical evaluation of the drug
promotional literature(1) DOAP (Batch A to H)
07-07-21 Wed
PA 27.9
Cardiomyopathies - Pathological
aspects and complications
Lecture
VI - Medicine, Physiology (nesting)
MI 8.9.1 Discuss the of
Blood collection of
microbial agent SGL(Batch
A to H)
CM 7.2.3 & 8.1.3 describe
the epidemiology, mode of
transmission of Amoebiasis
and Ascariasis SGL (Batch
A to H)
PH 1.42 Describe general
principles of Antimirobial
chemotherapy. B lactam
antibiotics (1) SGL (Batch A
to H)
--
08-07-21 Thu
SU2.1 Describe Pathophysiology
of shock, types of shock &
principles of
resuscitation including fluid
replacement and monitoring.
SU2.2 Describe the clinical
features of shock and its
appropriate treatment.
Lecture
PA 27.10
Cardiovascular syphilis -
Pathological aspects and
complications
SGL
HI - Microbiology (sharing)
VI - Medicine (nesting)
CM 8.3.2 Iodine deficiency
disorder and its
programme
VI-GENERAL MEDICINE,
PEDIATRICS LECTURE
PH 1.42 Describe general
principles of Antimirobial
chemotherapy. B lactam
antibiotics (2) SGL (Batch A
to H)
--
09-07-21 Fri
MI 8.2.1 Describe
Parasitological Oppurtunistic
infecions Lecture
VI General Medicine
HI Pathology (sharing)
IM 16.6 Distinguish between
diarrhea and dysentery
based on clinical
features
--
10-07-21 Sat
AETCOM Module 2.5.4
Bioethics continued – Case
studies on patient autonomy and
decision making Anchoring
Lecture
PH 1.42 Describe
general principles of
Antimirobial
chemotherapy.
Cephalosporins SGL
(Batch A to H)
MI 8.2.2 Fungal
Oppurtunistic infecions
Lecture
VI General Medicine
HI Pathology (sharing)
PH 5.5 Demonstrate an
understanding of the
caution in prescribing
drugs
likely to produce
dependence and
recommend the line of
management.
SGL (Batch A to H)
VI-Psychiatry.
MI 3.1.
Enumerate and describe
the epidemiology,
pathogenesis and clinical
feature of microbial agents
causing Dysentery Lecture
VI General Medicine and
Paediatrics HI
Pathology (Sharing)
Sports and Extra-curricular activities
11-07-21 Sun
12-07-21 Mon
PH1.29 Describe the mechanisms
of action, types, doses, side
effects,
indications and contraindications
of the drugs used in
congestive heart failure (1)
Lecture
VI Gen.Med.(Nesting)
PA 28.1
Normal histology of the
kidney
Lecture
Sports and Extra-curricular activities
13-07-21 Tue
PA 28.2
Clinical syndromes of renal
disease - Pathological aspects,
clinical, laboratory findings and
complications
Lecture
PH1.29 Describe the
mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in
congestive heart failure (2)
Lecture
VI Gen.Med.(Nesting)
MI 8.6.1
Biomedical Waste
Management
SGL (Batch A to H)
HI Community Medicine
(sharing)
CM 14.1,14.2,14.3 classify
hospital waste
SGL (Batch A to H)
HI Microbiology
--Clinical Posting
MI 3.2.3 Identify the
common etiologic agent of diarrhoea -Giardiasis
DOAP (Batch A to H)
VI General Medicine and Paediatrics
Formative assesment microbiology 2
FM 2.12 to 2.14
Describe the legal requirments to conduct postmortem
examination and procedures.
Discuss commen instuments used during autopsy.
Discibe and discuss obscure autopsy.
Examinations of clothing and viscera.
Chemical analysis and PM artifacts.SGL
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Sunday
14-07-21 Wed
OG 12.1.2 Describe principles of
management of hypertensive
disorders of pregnancy and
eclampsia, complications of
eclampsia HI MEDICINE
MI 8.6.2 Needle
stick injury
SGL (Batch A to H)
HI Community Medicine
(sharing)
PA 28.3
Acute renal failure -
Pathological aspects,
clinical, laboratory findings
and complications
SGL
VI -General Medicine
(nesting)
Pharmacology
Formative
Assessment -2
Feed back
--
15-07-21 Thu
PA 28.4
Chronic renal failure -
Pathological aspects, clinical,
laboratory findings and
complications
Lecture
VI -General Medicine (nesting)
PH1.29 Describe the
mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in
congestive heart failure
SDL
--
16-07-21 Fri
SU29.1 Describe the causes,
investigations and principles of
management
of Hematuria
Lecture
PA 28.5.1 to PA 28.5.4
Glomerulonephritis -
Pathological aspects,
clinical, laboratory findings
and complications
Lecture
VI - Physiology, Medicine
--
17-07-21 Sat
AETCOM 2.5.5
Bioethics continued – Case
studies on patient autonomy and
decision making
Case resolution
Pandemic
Module 2.3.5
Discussion and
closure
PA 28.5.5 to PA 28.5.9
Glomerulonephritis -
Pathological aspects,
clinical, laboratory findings
and complications
SGL
VI - Physiology, Medicine
FM 2.15
Describe special protocols
for conduction of medico-
legal atupsies in case of
death in costudy or folloing
violation of human right as
NHRC guide lines. SGL
MI 7.3.1 UTI Lecture
VI Gen medicine Sports and Extra-curricular activities
18-07-21 Sun
19-07-21 Mon
PA 28.13
Renal stone disease and
obstructive uropathy -
Pathological aspects, clinical,
laboratory findings and
complications
Lecture
VI - Surgery (nesting)
MI 7.3.2 UtI SGL Ecoli
VI Gen medicine
PH 1.48 Describe the
mechanisms of action,
types, doses, side
effects,indications and
contraindications of the
drugs used in UTI/ STD
and viral diseases including
HIV
Drugs for UTI and STD
SGL(Batch A to H)
HI-Microbiology (Sharing)
IM 10.8 Classify, describe and discuss
the significance of proteinuria in CKD--
20-07-21 Tue
PA 28.10
Pathology of chronic
pyelonephritis and reflux
nephropathy
Lecture
VI- Medicine (nesting)
HI - Pharmacology (sharing)
MI8.9.2 Sample processing
Urine SGL--
21-07-21 Wed
22-07-21 Thu
23-07-21 Fri
24-07-21 Sat
Clinical Posting
Clinical Posting
PH 2.3 Demonstrate the appropriate setting
up of an intravenous drip in a simulated
environment DOAP (Batch A to H)
MI 3.2.2 ECOLI DOAP
VI Gen medicine & Pediatrics
Clinical Posting FORMATIVE ASSESSMENT -1 COMMUNITY MEDICINE
MI 8.7.1
Universal precaution and Spill Management
DOAP (Batch A to H)
VI General Surgery HI
Community Medicine
Clinical Posting
Clinical Posting
Sunday
IDulAZHA
25-07-21 Sun
26-07-21 Mon
PH1.42 Describe general
principles of Antimicrobial
chemotherapy. Flouroquinolones
Lecture
PA 28.12
Pathology of cystic disease
of the kidney
SGL
VI - Medicine, Pediatrics
(nesting)
--
27-07-21 Tue
OG 6.1 Describe, discuss and
demonstrate the clinical features
of
pregnancy, derive and discuss its
differential diagnosis, elaborate
the principles underlying and
interpret pregnancy tests
PH1.42 Describe general
principles of Antimicrobial
chemotherapy.
Tetracycline and
chloramphenicol. Lecture
PA 28.11
Vascular disease of the
kidney - Pathological
aspects, clinical,
laboratory findings and
complications
SGL
VI - Medicine (nesting)
PH1.53-Describe heavy
metal poisoning and
chelating agents.
SGL (Batch A to H)
--
28-07-21 WedCM 10.5.1
Immunizing agents and AEFI SDL
PA 28.15
Thrombotic angiopathies -
Pathological aspects,
clinical, laboratory findings
and complications
SGL
VI -Medicine (nesting)
PH1.60-Describe and
discuss
Pharmacogenomics and
Pharmacoeconomics.
SGL 9Batch A to H)
MI7.3.3 Schistosoma SGL
VI Gen Medicine--
29-07-21 Thu
PA 28.14
Renal tumors - Pathological
aspects. presenting features and
progression
Lecture
VI - Pediatrics (nesting)
MI6.1.1. Corynebacterium
Lecture
MI8.9.7 Sample collecttion
for URTI SGL
PH3.6 Opimize interacion
wih Pharma representaive
SGL(Batch A to H)
--
30-07-21 Fri
SU29.2 Describe the clinical
features, investigations and
principles of
management of congenital
anomalies of genitourinary system
Lecture
MI6.1.2 Viral causes URTI
SGL
VI - Gen. Medicine (nesting)
PA 26.2
Lung abscess -
Pathological aspects,
clinical, laboratory findings
and complications
SGL
HI - Micro (sharing)
VI - Medicine (nesting)
MI6.1.4 LRtI SGL
VI - Gen. Medicine (nesting) --
31-07-21 Sat
IM 3.1 Define,
discuss, describe and
distinguish
community acquired
pneumonia,
nosocomial
pneumonia and
aspiration pneumonia
PH1.42 Describe
general principles of
Antimicrobial
chemotherapy.
Macrolides and
miscellaneus
antimicrobials.
SGL (Batch A to H)
PA 28.16
Pathological aspects and
presenting features of
urothelial tumors
Lecture
VI - Surgery (nesting)
--
01-08-21 Sun
Clinical Posting
Clinical Posting
Clinical Posting
Pandemic Module 2.4.3 visit tto PHC
(COMMUNITY MEDICINE)
AETCOM 2.6.2
Bioethics continued: Case studies on autonomy
and decision making
Self directed learniing
PH3.1 Write a rational, correct and legible generic
prescription for a given condition and communicate the
same to the patient (3)
DOAP (Batch A to H)
Clinical Posting
Clinical Posting
Sunday
Sunday
02-08-21 Mon
PA 26.1
Pneumonia - Pathological
aspects, clinical, laboratory
findings and complications
Lecture
HI - Micro (sharing)
VI - Medicine (nesting)
PH1.33 Describe the
mechanism of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in cough
(antitussives, expectorants/
mucolytics)
SDL
VI-Resp.Med.
--
03-08-21 Tue
PH 1.32.Describe the
mechanism/s of action, types,
doses, side effects,indications
and contraindications of drugs
used in bronchial asthma
and COPD (1)
Lecture
VI--Resp.Med.
MI 6.1.5 C pneumophila
SGL
VI Gen medicine(NESTING)
PA 26.3
Pathology of obstructive
airway disease (OAD) and
bronchiectasis
Lecture
HI - Micro, Pharma
(sharing)
VI - Medicine Physiology
(nesting)
PH 1.32.Describe the
mechanism/s of action,
types, doses, side
effects,indications and
contraindications of drugs
used in bronchial asthma
and COPD (1)
Lecture
VI--Resp.Med.
--
04-08-21 Wed
PA 26.4.1 to PA 26.4.5
Pathology of pulmonary
tuberculosis Lecture
HI -Micro, Pharma (sharing)
VI - Medicine (nesting)
MI6.1.3 TB Lecture
VI Gen medicine
PA 26.4.6 to PA 26.4.10
Pathology of pulmonary
tuberculosis
SGL
HI - Micro and Pharma
(sharing)
VI - Medicine (nesting)
PH 1.44 Describe the first
line antitubercular dugs,
their mechanisms of action,
side effects and doses (1).
Lecture
VI-Resp.Med.
--
05-08-21 Thu
AETCOM 2.6.3
Bioethics continued: Case studies
on autonomy and decision making
Anchoring Lecture
PH1.44-Describe the first
line antitubercular dugs,
their mechanisms of
action, side effects and
doses. (2)
Lecture
VI-Resp.Med.
OG 8.8 Enumerate the
indications and describe
the investigations
including
the use of ultrasound in
the initial assessment
and monitoring in
pregnancy
FM 2.16.1
Describe and discuss
examination of mutilated
bodies or fragments chart
bone and bundle of bones.
SGL--
06-08-21 Fri
PH1.45 Describe the dugs used in
MDR and XDR Tuberculosis
Lecture
VI-Resp.Med.
HI-Microbiology
PA 26.5
Occupational lung disease -
Pathological aspects and
complications.
SGL
VI - Community Medicine,
Medicine (nesting)
MI 6.1.6 Mycoplasma
SGL
VI Gen medicine
Formative assesmen
test 3
Feedback
--
07-08-21 Sat
AETCOM 2.6.4
Bioethics continued: Case studies
on autonomy and decision making
Discussion and closure of case
SU29.3 Describe
the Clinical
features,
Investigations and
principles of
management of
urinary tract
infections
Lecture
Forensic Medicine
Formative assesment--
08-08-21 Sun
Clinical Posting
MI6.3.2 AFB staining DOAP
VI Gen medicine
Clinical Posting
Clinical Posting
Pandemic module 2.4.1, 2.4.2, 2.4.4 EXPLORATORY SESSION, SGD, DISCUSSION
AND CLOSURE
(COMMUNITY MEDICINE)
Clinical Posting
Clinical Posting
Sunday
09-08-21 Mon
PA 26.6 and 26.7
Pathology of tumors of the lung
and pleura
Lecture
VI - Community Medicine,
Medicine (nesting)
MI6.1.8 Deep Mycosis SGL --
10-08-21 Tue
PH1.51 Describe occupational and
environmental pesticides, food
adulterants, pollutants and insect
repellents
Lecture
PA 26.6 and 26.7
Pahology of tumors of the
lung and pleura SGL
VI - Community Medicine,
Medicine (nesting)
--
11-08-21 WedMI 6.1.1 to 6.1.3
Corynebacterium/TB SDL
PA 29.2
Pathological aspects of
carcinoma of the penis
SGL
VI - Surgery (nesting)
PA 29.3
Pathological aspects of
benign prostatic
hyperplasia
Lecture
VI - Surgery (nesting)
PH 1.13 Describe
mechanism of action,
types, doses, side effects,
indications and
contraindications of
adrenergic and anti-
adrenergic
drugs. Drugs for BPH SGL
(Batch A to H)
Sharing with Pathology
--
12-08-21 Thu
AETCOM 2.7.1
Bioethics continued: Case studies
on autonomy and decision making
Introduction of case
PH 1.40 Describe
mechanism of action,
types, doses, side effects,
indications and
contraindications of 1.
Drugs used in the
treatment
of infertility, and 2. Drugs
used in erectile
dysfunction. Drugs used in
erectile dysfunction and
inferliliy
SGL (Batch A to H)
VI-Obs.Gynae
CM 11.2 Describe the role,
benefits and functioning of
the employees state
insurance scheme
SGL
PA 29.5
Pathology and progression
of prostatitis
SGL
VI - Surgery (nesting)
FM 4.18.4 to 4.19.2
13-08-21 Fri
AETCOMFM 4.11.1 to 4.11.3 and
4.18.1
Euthanasia and defination and
types of medical negligence
Lecture
MI7.1.1 Chlamydia
Lecture
VI Gen SURGERY
--
14-08-21 Sat
PA 29.1
Pathology of testicular tumors,
diagnostic tests and progression
Lecture
VI - Surgery (nesting)
PH1.37 Describe the
mechanisms of
action, types, doses,
side effects,
indications and
contraindications of
the drugs used as sex
hormones, their
analogues and
anterior Pituitary
hormones. anterior
Pituitary hormones
Lecture
MI7.2.1 Syphilis
Lecture
VI-Obs.Gynae,derma
OG 9.1.1 Classify,
define and discuses
the aetiology and
management of
abortions including
threatened,
incomplete,
inevitable,
CM 8.1.5 epidemiology of
Emerging and re-emerging
infections
SGL (Batch A to H)
MICROBIOLOGY AND
PPATHOLOGY (NESTING)
VI Gen Med.
--
15-08-21 Sun
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Independence Day
MI6.3.1 LRTI DOAP agents gram stain
FM 2.17.1 and 2.18.1 to 2.18.3
Describe and discuss exhumation, Crime scene
investigation and Discuss the crime scene visit, the
duties and responsibilites of doctors on crime scene and
the reconstruction of sequence of events after crime
MI1.2.2 ZN stain DOAP
Pharmacology Formative Assessment -
3
16-08-21 Mon
PH 1.37 Describe the mechanisms
of action, types, doses, side
effects,
indications and contraindications
of the drugs used as sex
hormones, their analogues and
anterior Pituitary hormones.Sex
hormones
Lecture
PA 30.1
Carcinoma of the cervix-
Epidemiology, pathological
aspects and progression
Lecture
VI - Obs and Gynaec
(nesting)
MI 7.2.3 Trichomonas
SGL
VI Obs.Gynae,derma
PH 1.37 Describe the
mechanisms of action,
types, doses, side
effects,indications and
contraindications of the
drugs used as sex
hormones, their analogues
and anterior Pituitary
hormones.Sex hormones
SDL
--
17-08-21 Tue
SU29.4 Describe the clinical
features, investigations and
principles of
management of hydronephrosis
Lecture
PA 30.3
Leiomyomas and
leiomyosarcomas
SGL
VI - Obs and Gynaec
(nesting)
PA 30.2
Carcinoma of the
endometrium - Pathology,
diagnosis and progression
Lecture
VI - Obs and Gynaec
(nesting)
PH 1.39 Describe
mechanism of action,
types, doses, side effects,
indications and
contraindications the drugs
used for contraception.
SGL(Battch A-D)
VI-Obs Gynae
--
18-08-21 Wed
PA 29.4
Carcinoma of the prostate -
Pathology, diagnostic tests and
progression
Lecture
VI - Surgery (nesting)
OG 9.1.2 Classify, define
and discuses the aetiology
and management of
abortions including missed
and septic
PA 30.4.1 to PA 30.4.3
Ovarian tumors -
Pathological aspects
SGL
VI - Obs and Gynaec
(nesting)
PA 30.4.4 to PA 30.4.6
Ovarian tumors -
Pathological aspects
SGL
VI - Obs and Gynaec
(nesting)
--
19-08-21 Thu
20-08-21 Fri
Pandemic Module 2.5.1 EXPLORATORY AND
INTERACTIVE SESSION NEW DRUG
DEVELOPMENT
PHARMACOLOGY/MEDICINE
CM Formative assesment --
21-08-21 Sat
PA 30.5
Pathology of
gestational
trophoblastic
neoplasms.
SGL
VI - Obs and Gynaec
(nesting)
--
22-08-21 Sun
23-08-21 MonAITO week Diabetes
mellitus
PA 32.4.1 to PA 32.4.6
Pathology of diabetes
mellitus - Part 1
Lecture
VI - Medicine, Physiology
CM 8.2.4 & 7.2.8
Describe and discuss the
epidemiology, conrol
measures including lab
ttestt at primary care level
for DIABETES MELLITUS
Lecture
VI Gen Med.
IM 11.1 Define and classify
diabetes --
Muharram
Raksha Bandhan
AETCOM 2.7.2
Bioethics continued: Case studies on autonomy and
decision making
SDL
Pathology Formative assesment
test 5
Pandemic Module 2.5.2 SGD
NEW DRUG DEVELOPMENT
PHARMACOLOGY/MEDICINE
Pandemic Module 2.5.3 VISIT TO PHARMACEUTICAL
FIRM
PHARMACOLOGY/MEDICINE
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
24-08-21 Tue
PH1.36 Describe the mechanism
of action, types, doses, side
effects,
indications and contraindications
of drugs used in endocrine
disorders (diabetes mellitus,
thyroid disorders and
osteoporosis) Insulin
Lecure
VI--Gen.Med.
PA32.4.7 to PA 32.4.11
Pathology of diabetes
mellitus - Part 2
Lecture
VI - Medicine, Physiology
CM 8.2.5 & 7.2.9
Describe and discuss the
epidemiology, conrol
measures including lab
ttestt at primary care level
for OBESITY
Lecture
VI Gen Med.
PH1.36 Describe the
mechanism of action,
types, doses, side effects,
indications and
contraindications of drugs
used in endocrine
disorders (diabetes
mellitus, thyroid disorders
and osteoporosis) Oral
hypoglycemic drugs
Lecure
VI--Gen.Med.
--
25-08-21 Wed
PH1.36 Describe the mechanism
of action, types, doses, side
effects,
indications and contraindications
of drugs used in endocrine
disorders (diabetes mellitus,
thyroid disorders and
osteoporosis) Insulin analogues
Lecture
VI-Gen.Med.
SU24.2 Describe the
clinical features, principles
of investigation, prognosis
and management of
pancreatic endocrine
tumours
Lecture
--
26-08-21 Thu
IM 11.5 Describe and discuss the
pathogenesis and temporal
evolution of
microvascular and macrovascular
complications of diabetes
OG 12.3.1 Define, classify
and describe the etiology,
pathophysiology,
diagnosis, investigations,
criteria,of diabetes in
pregnancy
SU24.3 Describe the
principles of investigation
and management of
Pancreatic disorders
including pancreatitis and
endocrine tumors.
Lecture
CM 8.3.3 National
Programme
for Prevention & Control of
Cancer, Diabetes,
Cardiovascular Disease
and Stroke
Lecture
VI General Medicine
--
27-08-21 Fri
PE 33.4 DIABTES MELLITUS IN CHILDREN
(PEDIATRICS)
CM 5.1 Describe the common
sources of various nutrients and
special
nutritional requirements
according to age, sex, activity,
physiological
conditions SDL
OP 8.3 & 8.4 Retinal changes in
diabetic retinopathy and its
management
lecture (ophthalmology)
Reserve --
28-08-21 Sat
AETCOM 2.7.3
Bioethics continued: Case studies
on autonomy and decision making
Anchoring Lecture
IM11. 2 Describe and discuss
the epidemiology and
pathogenesis and risk
factors and clinical evolution
of type 1 diabetes
CM 8.1.6 Antimirobial
Resisttance
HI Mircobiology
LECTURE
OG 12.3.2 Discuss
adverse effects on the
mother and
foetus and the
management during
pregnancy and labor,
and
complications of
diabetes in pregnancy
Pathology Formative
Assesment Test 5
Feed back
CM 19.3 Describe
counterfiet medicine and
its prevention SGL (Batch A
to H)
HI- PHARMACOLOGY
--
29-08-21 Sun
30-08-21 Mon
Clinical Posting
PH 3.1 Write a rational, correct and legible generic
prescription for a given condition and communicate the
same to the patient for diabetes (4)
DOAP (Batch A to H)
Clinical Posting
Janmasthmi
Clinical Posting
Clinical Posting
Sunday
31-08-21 Tue
SU6.1 Define and describe the aetiology
and pathogenesis of surgical
Infections
Lecture
MI 7.1.2 Neisseria
SGLVI-GEN SURGERY
PH1.36- Describe the
mechanism of action,
types, doses, side
effects,indications and
contraindications of drugs
used in endocrine
disorders (diabetes
mellitus, thyroid disorders
and osteoporosis). Drugs
for Diabetes Mellitus
SDL
CM 8.2.3 & 7.2.7
Describe and discuss the
epidemiology, control
measures including lab
ttestt at primary care level
for STROKE
LECTURE
VI Gen Med.
--
01-09-21 Wed
PH 1.18 Describe the mechanism/s
of action, types, doses, side
effects,
indications and contraindications
of general anaesthetics, and
preanesthetic
medications(1)
Lecture
VI-Anaes.
PA 30.6
Pathology of cervicitis
SGL VI -
Obs and Gynaec (nesting)
--
02-09-21 ThuMI 1.4.1 to 1.4.2 Sterilization and
disinfection SDL
PA 30.7 and PA 30.8
Pathology of adenomyosis
and endometriosis
SGL
VI - Obs and Gynaec
(nesting)
PH 1.18 Describe the
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of
general anaesthetics, and
preanesthetic
medications(2)
Lecture
VI-Anaes.
AETCOM FM 4.18.2 to
4.18.5
Description of deffirent
kinds of negligence,
vicarious libality and Res
ipsa loquitor.
Defence against
negligence.
SGL
--
03-09-21 Fri
IM 21.1 Describe the initial
approach to the
stabilisation of the patient who
presents with poisoning
PA30.9
Pathology of endometrial
hyperplasia
SGL
VI - Obs and Gynaec
(nesting)
MI7.1.3 Enterobius SGL
VI-GEN SURGERY
Pharmacology
Formative
Assessment -3
Feed back
--
04-09-21 Sat
AETCOM 2.7.4
Bioethics continued: Case studies
on autonomy and decision making
Discussion and closure of case
PH1.23 Describe the
process and
mechanism of drug
deaddiction
Lecture
MI 7.2.2 Hemphilus
SGL
VI-OBS GYNAE AND
DERMATOLOGY
PA 31.1 and PA 31.4
Pathology of benign
breast diseases and
gynaecomastia - Part
1
SGL
VI - Surgery, Anatomy
(nesting)
PH1.20 Describe the
effects of acute and
chronic ethanol intake.
PH1.21-Describe the
symptoms and
management of methanol
and ethanol poisonings
SGL(Batch A to H)
Pandemic module 2.5.4
DISCUSSION
NEW DRUG
DEVELOPMENT
PHARMACOLOGY/MED
ICINE
PA10.4
Pathology of common
bacterial, viral, protozoal
and helminthic diseases
SDL
--
05-09-21 Sun
06-09-21 Mon
07-09-21 Tue
08-09-21 Wed
09-09-21 Thu
10-09-21 Fri
11-09-21 Sat
12-09-21 Sun
13-09-21 Mon
MI 1.2.2 ZN staning DOAP
Iind TerminaL
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Iind TerminaL
Sunday
Sunday
14-09-21 Tue
OG 9.5 Describe the
etiopathology, impact on maternal
and fetal health and
principles of management of
hyperemesis gravidarum
PA 31.1 and PA 31.4
Pathology of benign breast
diseases and
gynaecomastia - Part 2
SGL
VI - Surgery, Anatomy
(nesting)
--
15-09-21 Wed
PH1.19 Describe the mechanism/s
of action, types, doses, side
effects,
indications and contraindications
of the drugs which act on CNS,
(including anxiolytics, sedatives &
hypnotics, anti-psychotic, anti
depressant drugs, anti-maniacs,
opioid agonists and antagonists,
drugs used for neurodegenerative
disorders, anti-epileptics drugs)
Sedatives and hypnotics(1)
Lecture
VI-Psychiatry,Phy.
MI 5.1.1 - Meningitis
(Group B streptococcus)
Lecture
VI GEN.MEDICINEAND
PAEDIATRICS
HI PATHOLOGY
PA 31.2
Pathology of carcinoma of
breast
Lecture
VI - Surgery (nesting)
PH1.37 Describe the
mechanisms of action,
types, doses, side
effects,indications and
contraindications of the
drugs used as sex
hormones, their analogues
and anterior Pituitary
hormones. Drugs for Ca
breast SGL
--
16-09-21 Thu
ClholiSU6.2 Enumerate
Prophylactic and therapeutic
antibiotics
Plan appropriate management
Lecture
PA 31.2
Pathology of carcinoma of
breast
SGL
VI - Surgery (nesting)
--
17-09-21 Fri
MI 5.1.2 Neisseria
Lecture VI GEN.MEDICINE AND
PAEDIATRICS
HI PATHOLOGY
PH1.19 Describe the
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs which act on CNS,
(including anxiolytics,
sedatives & hypnotics, anti-
psychotic, anti depressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for
neurodegenerative
disorders, anti-epileptics
drugs) Sedatives and
hypnotics (2)
Lecture
VI-Psychiatry,Phy.
MI8.9.6 Sample collecion
CSF SGL
PH1.19 Describe the
mechanism/s of action,
types, doses, side
effects,indications and
contraindications of the
drugs which act on CNS,
(including anxiolytics,
sedatives & hypnotics, anti-
psychotic, anti depressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for
neurodegenerative
disorders, anti-epileptics
drugs) . Anti-psychotics
Lecture
VI-Psychiatry,Phy.
--
Formative assesment MICRO
Clinical Posting
Clinical Posting
2 nd terminal Community Medicine
PA 31.3
Describe and identify morphologic and microscopic
features of carcinoma of the breast
DOAP (Batch A to H)
VI - Surgery (nesting)
18-09-21 Sat
CM 11.1 Enumerate and Describe
the presentting features of
pattients with occupational illness
including agriculture
LECTURE
MI5.1.3 Meningittis
(Polio) LectureVI
GEN.MEDICINE
PAEDIATRICS
HI PATHOLOGY
PA 35.1
Etiology, types,
pathogenesis and
CSF findings in
meningitis
Lecture
VI - Medicine
(nesting)
HI- Microbiology
(sharing)
MI5.1.4 Meningitis
(Herpes) LecureVI
GEN.MEDICINE
,Paediatrics
HI PATHOLOGY
PH1.19 Describe the
mechanism/s of action,
types, doses, side
effects,indications and
contraindications of the
drugs which act on CNS,
(including anxiolytics,
sedatives & hypnotics, anti-
psychotic, anti depressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for
neurodegenerative
disorders, anti-epileptics
drugs) . Anti-psychotics
SDL
IM 17.13 Describe the
pharmacology, dose,
adverse reactions and
regimens
of drugs used in the
treatment of bacterial,
tubercular and viral
meningitis
FM 4.21 & 4.8
Describe product liablity
and medical indemnity
insurance and consumer
protection act 1986,
workmen compensation act
and ESI act.
SGL
--
19-09-21 Sun
20-09-21 Mon
PA 35.2.1 to PA 35.2.3
Pathology of CNS tumours - Part 1
Lecture
VI - Pediatrics (nesting)
PA 35.1
Pathology of different
forms of meningitis
SGL
VI - Medicine (nesting)
HI- Microbiology (sharing)
--
21-09-21 Tue
MI 5.1.5 Meningitis (Rubella)
Lecture
VI GEN.MEDICINE, Pediatrics
HI Pathology
PA 35.2.4 to PA 35.2.7
Pathology of CNS tumours -
Part 2
SGL
VI - Pediatrics (nesting)
MI5.1.6 Meningitis
(Acanthameba,toxoplasma)
Lecture
VI GEN.MEDICINE,
Pediatrics
HI Pathology
CM 7.2.5 & 8.1.7 describe
the epidemiology, mode of
transmission of
meningococcal meningitis
SGL Batch (A-D)
VI Gen-Medicine
--
22-09-21 Wed
PH1.19 Describe the mechanism/s
of action, types, doses, side
effects,indications and
contraindications of the drugs
which act on CNS, (including
anxiolytics, sedatives & hypnotics,
anti-psychotic, anti depressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for neurodegenerative
disorders, anti-epileptics drugs) .
Anti-depressants(1)
Lecture
VI-Psychiatry,Phy.
MI 5.1.7 Meningitis
(Crypptococcus) Lecture
VI GEN.MEDICINE,
Pediatrics
HI Pathology
--
Clinical Posting
Clinical Posting
Clinical Posting
PA 35.3
Identify the etiology of meningitis based on given CSF
parameters
DOAP (Batch A to H)
VI - Medicine (nesting)
HI- Microbiology (sharing)
Pathology Formative assesment 6
Sunday
23-09-21 Thu
OG 9.3 Discuss the aetiology,
clinical features, differential
diagnosis of
acute abdomen in early pregnancy
(with a focus on ectopic
pregnancy) and enumerate the
principles of medical and surgical
management
PH1.19 Describe the
mechanism/s of action,
types, doses, side
effects,indications and
contraindications of the
drugs which act on CNS,
(including anxiolytics,
sedatives & hypnotics, anti-
psychotic, anti depressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for
neurodegenerative
disorders, anti-epileptics
drugs) . Anti-
depressants(2)
Lecture
VI-Psychiatry,Phy.
--
24-09-21 Fri
PA 34.2
Pathological aspects of basal cell
carcinoma of skin
Lecture
VI - Dermatology (nesting)
MI 5.2.1 Encephalitis
( Dengue) LectureLecture
VI GEN.MEDICINE,
Pediatrics
HI Pathology
--
25-09-21 Sat
AETCOM 2.8.2 What does
it mean to be family member of a
sick patient? Large
Group Discussions with patients’
relatives
CM 7.2.6 & 8.1.8
describe the
epidemiology, mode
of transmission of
STDs.
Lecture
VI Skin & VD
Pathology
Formative assesment 6
Feedback
--
26-09-21 Sun
27-09-21 Mon
PA 33.1
Pathology of osteomyelitis
Lecture
VI - Anatomy, Orthopaedics
(nesting) HI -
Microbiology (sharing)
MI4.2.1 Bone and joint
infecions
(Stapphylococcus) Lecture
VI ORTHOPAEDICS
--
Clinical Posting
Clinical Posting
Clinical Posting MI 6.2 URTI DOAP
AETCOM 2.8.1 What
does it mean to be family member of a sick patient?
Hospital visit and interviews
Pharmacology Formative Assessment -
4
PH4.2 Demonstrate the effects of drugs on
blood pressure (vasopressor and vaso-
depressors with appropriate blockers) using
computer aided learning (2). Frog Heart
DOAP (Batch A to H)
PH 1.12 Calculate the dosage of drugs using appropriate
formulae for an individual patient, including children,
elderly and patient with renal
dysfunction. DOAP(Batch A to H)
Sunday
28-09-21 Tue
PH 1.36 Describe the mechanism
of action, types, doses, side
effects,
indications and contraindications
of drugs used in endocrine
disorders (diabetes mellitus,
thyroid disorders and
osteoporosis).Calcium metabolism
and drugs for osteoporosis.
Lecture
VI--Gen.Med.
PH1.19 Describe the
mechanism/s of action,
types, doses, side
effects,indications and
contraindications of the
drugs which act on CNS,
(including anxiolytics,
sedatives & hypnotics, anti-
psychotic, anti depressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for
neurodegenerative
disorders, anti-epileptics
drugs) . Opiod agonists(1)
SGL (Batch A to H)
VI-Psychiatry,Phy.
PA 33.2.1 to PA 33.2.4
Pathology of primary and
metastatic ttumour of bone -
Part 1
SGL
VI - Orthopaedics (nesting)
MI 4.2.2 Bone infecions
(Pseudomonas) Lecture
VI Orthopaedics
--
29-09-21 Wed
MI 4.3.3 Skin and sof ttisue
infection (Superficial
mycoses)Lecture
VI dermatology &GEN.surgery
MI 8.9.4 Collection of
sampple (Pus) SGL
PA 33.2.5 to PA 33.2.8
Pathology of primary and
metastatic ttumour of bone -
Part 2
SGL
VI - Orthopaedics (nesting)
PH1.19 Describe the
mechanism/s of action,
types, doses, side
effects,indications and
contraindications of the
drugs which act on CNS,
(including anxiolytics,
sedatives & hypnotics, anti-
psychotic, anti depressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for
neurodegenerative
disorders, anti-epileptics
drugs) . Opiod angonists
(2)
SGL (Batch A to H)
VI-Psychiatry,Phy.
--
Clinical Posting
Clinical Posting
30-09-21 Thu
SU9.1 Choose appropriate
biochemical, microbiological,
pathological,
imaging investigations and
interpret the investigative data in
a
surgical patient
PH1.19 Describe the
mechanism/s of action,
types, doses, side
effects,indications and
contraindications of the
drugs which act on CNS,
(including anxiolytics,
sedatives & hypnotics, anti-
psychotic, anti depressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for
neurodegenerative
disorders, anti-epileptics
drugs) . Opiod antagonists
SGL (Batch A to H)
VI-Psychiatry,Phy.
01-10-21 Fri
AETCOM 2.8.4
What does it mean to be family
member of a sick patient?
Discussion and closure
CM 7.2.6 & 8.1.8 describe
the syndromic management
of STDs.
Lecture
VI Skin & VD
MI 4.2.3 Bone and jointt
infection
((Mycetoma)Lecture
VI orthopaedics
PA 33.3
Pathology of soft tissue
tumors
SGL
VI - Orthopedics (nesting)
02-10-21 Sat
03-10-21 Sun
04-10-21 Mon
AETCOM FM 4.19.1 to 4.19.2
Define and Described conscent its
types. Rules of consent in relation
to age emergency mental illness
and alcohol intoxication. Lecture
IM 7.5 Describe and
discriminate acute,
subacute and chronic
causes of
joint pain
PA 33.5
Pathology of rheumatoid
arthritis
SGL
VI - Medicine (nesting)
PH1.16 Describe
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs which act by
modulating autacoids,
including: anti-histaminics,
5-HT modulating
drugs, NSAIDs, drugs for
gout, anti-rheumatic drugs,
drugs for
migraine.Drugs for RA
Lecture
HI-Pathology (Sharing)
VI-Gen.Med.
--
Clinical Posting MI 1.2.3 Sool microscoppy DOAP
Clinical Posting
Clinical Posting
Gandhi Jayanti
05-10-21 Tue
PH 1.19 Describe mechanism/s of
action, types, doses, side effects,
indications and contraindications
of the drugs which act by
modulating autacoids, including:
anti-histaminics, 5-HT modulating
drugs, NSAIDs, drugs for gout,
anti-rheumatic drugs, drugs for
migraine.Drugs for Gout
Lecture
VI-Gen.Med.
Pharmacology Formative
Assessment Feed back - 4
MI 4.3.1 Skin and soft
tissue infection (Leprosy(
Lecture)
VI DERMA AND
GEN.MEDICINE
PA10.3
Pathogenesis and
pathology of leprosy
Lecture
HI - Microbiology (sharing)
VI - Medicine (nesting)
PH 1.46 Describe the
mechanisms of action,
types, doses, side
effects,indications and
contraindications of
antileprotic drugs.SGL
(Batch A to H)
HI-Pathology
(Sharing),Micro.(Nesting)
VI--Dermatology
--
06-10-21 Wed
OG 14.1 Enumerate and discuss
the diameters of maternal pelvis
and types VI ANATOMY
MI 8.1.6 Zoonotic ds
(Echinococcus) SGL
VI GEN. MEDICINE
PA10.2
Pathogenesis and
pathology of cysticercosis
SGL
HI - Microbiology (sharing)
VI - Medicine (nesting)
PH 1.47 Describe the
mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in malaria,
KALA-AZAR, amebiasis and
intestinal helminthiasis.Anti-
helminthic drugs
SGL (Batch A to H)
HI-Pathology
(Sharing),Micro.(Nesting)
VI-Gen.Med.
--
07-10-21 Thu MI 8.1.1 Plague SDL
PA 33.4
Pathology of Paget's
disease of bone
SGL
VI - Orthopedics (nesting)
--
08-10-21 Fri
PA 32.6
Pathology of pancreatic cancer
Lecture
VI - Surgery
FM 4.20 & 4.24
Describe therapeutic
privilage malingring,
therapeutic missadventure,
Professional secrecy,
Humen experimentation.
SGL
MI 4.3.4 Skin infecions
(Dermatophytes) LECTURE
VI- Dermattology,Gen
Surgery
PH 1.42 Describe general
principles of antimicrobial
chemotherapy.Anti-fungal
drugs(1) SGL (Batch A to H)
HI-Microbiology (Sharing)
--Clinical Posting
Microbiology Formative assesment
Clinical Posting
Clinical Posting
Clinical Posting
09-10-21 Sat
CLSU9.2 Biological basis for early
detection of cancer and
multidisciplinary
approach in management of
cancer
Lecture
PA 36.1
Patholgy of
retinoblastoma
SGL
VI - Opthalmology
MI4.3.5 Skin
infections Sub
cutaneous mycoses
LectureVI-
Dermattology,Gen
Surgery
PH 1.42 Describe
general principles of
antimicrobial
chemotherapy.Anti-
fungal drugs(2)
SGL (Batch A to H)
HI-Microbiology
(Sharing)
Mi 4.3.6 Skin infections Pox
virus Lecture
VI- Dermattology,Gen
Surgery
PH 1.19 Describe the
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs which act on CNS,
(including anxiolytics,
sedatives & hypnotics, anti-
psychotic, antidepressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for
neurodegenerative
disorders, anti-epileptics
drugs).Drugs used for
neuro degeneraive
disorders
SGL (Batch A to H)
VI-Psychiatry, Phy.
PA18.1
Causes of leucocytosis,
leucopenia, lymphocytosis
and leukemoid reactions
SGL
--
10-10-21 Sun
11-10-21 Mon
CM 8.3.5 UNIVERSAL
IMMUNZATION PROGRAMME
SGL
clinical lecure
MI4.1.2 Clostridium tetani
and Clostridium botulinum
Lecture
VI General Medicine
MI 8.9.5 Collection of
sample for fungus SGL--
12-10-21 Tue
Mi 4.3.6 Skin infections Pox virus
Lecture
VI- Dermattology,Gen Surgery
PH 1.19 Describe the
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of the
drugs which act on CNS,
(including anxiolytics,
sedatives & hypnotics, anti-
psychotic, antidepressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for
neurodegenerative
disorders, anti-epileptics
drugs).Drugs used for
neuro degeneraive
disorders
SGL (Batch A to H)
VI-Psychiatry, Phy.
PA18.1
Causes of leucocytosis,
leucopenia, lymphocytosis
and leukemoid reactions
SGL
--
Clinical Posting
Clinical Posting
Sunday
13-10-21 Wed
PH 1.19 Describe the mechanism/s
of action, types, doses, side
effects,
indications and contraindications
of the drugs which act on CNS,
(including anxiolytics, sedatives &
hypnotics, anti-psychotic,
antidepressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for neurodegenerative
disorders, anti-epileptics
drugs).Antiparkinsonian drugs
Lecture
VI-Psychiatry,Phy.
MI2.5.5 Filariasis Lecture
HI--Patthology(sharing)
VI-- Gen medicine
PA 18.2.1 to PA 18.2.4
Acute leukemias
Lecture
PA19.1
Causes and differentiating
features of
lymphadenopathy
SGL
VI -Surgery (nesting)
--
14-10-21 Thu
15-10-21 Fri
16-10-21 Sat
17-10-21 Sun
18-10-21 Mon
PA 18.2.5 to PA 18.2.8
Chronic leukemias
Lecture
PH 1.31 Describe the
mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in the
management of
dyslipidemias(1)
SGL (Batch A to H)
VI-Gen.Med.
--
19-10-21 Tue
20-10-21 Wed
IM 4.5 Describe and discuss the
pathophysiology and
manifestations of
malignant causes of fever
including hematologic and lymph
node
malignancies
PA 19.2
Pathology of tuberculous
lymphadenitis
SGL
VI -Surgery (nesting)
--
21-10-21 ThuMI 2.5.8 Common parasites
Fasciola hepatica SDL
PA 19.6
Causes of splenomegaly
SGL
VI - General Surgery,
Medicine (nesting)
--
22-10-21 Fri
FM 2.20.1 to 2.20.3
Define classify, describe
medicolegal interpretation of PM
findings.
Lecture
PH 1.31 Describe the
mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in the
management of
dyslipidemias(2)
SGL (Batch A to H)
VI-Gen.Med.
--
Clinical Posting
Clinical Posting
MI 2.6.2 Filariasis DOAP
VI-- Gen medicine
PA19.3
Identify and describe features of tuberculous
lymphadenitis in a gross and microscopic specimen
DOAP
PH 4.2 Demonstrate the effects of drugs on blood
pressure (vasopressor and vaso-depressors with
appropriate blockers) using computer aided learning (3)
DOAP(Batch A to H)
FM 2.21.1 to 2.21.5 DOAP
Hanging strangulation including clinical findings cause
of death PM findings preservation and dispatch of
ligature material.
Differentiate between hanging and strangulation.
Dussehra
EID-E-MILAD UN NABI
Clinical Posting
Clinical Posting
Clinical Posting
Sunday
23-10-21 Sat
MI2.5.7 Commom parasites
prevelant in India Lecture
HI--Patthology(sharing)
VI-- Gen medicine
PH 1.58 Describe
drugs used in Ocular
disorders (Glaucoma)
SGL(Batch A to H)
VI-Ophthal.
PH1.43 Describe and
discuss the rational
use of antimicrobials
including antibiotic
stewardship program
SGL
PA 19.4.1 to PA
19.4.2
Pathology of non-
Hodgkin's lymphoma
SGL
VI -Surgery (nesting)
SU10.1 Describe the
principles of perioperative
management of common
surgical procedures
Lecture
MI 8.6.3 Antimicrobial
stewardship SGL
CM 8.3.6 RNTCP
SGL--
24-10-21 Sun
25-10-21 MonMI 2.5.9 Ebola and Marburg fever
SDL
PH 1.58 Describe drugs
used in Ocular disorders
SGL(Batch A to H)
VI--Ophthal
--
26-10-21 Tue
IM 4.4 Describe and discuss the
pathophysiology and
manifestations of
inflammatory causes of fever
PA 19.4.3 to PA 19.4.4
Pathology of non-Hodgkin's
lymphoma
SGL
VI -Surgery (nesting)
--
27-10-21 Wed
SU10.2 Describe the steps and
obtain informed consent in a
simulated
environment
Lecture
PA 19.4.5 to PA 19.4.7
Pathology of Hodgkin's
lymphoma
SGL
VI -Surgery (nesting)
--
28-10-21 Thu
MI 2.5.1 Kala azar Lecture
HI--Patthology(nesting)
VI-- Gen medicine
PH1.47 Describe the
mechanisms of action,
types, doses, side effects,
indications and
contraindications of the
drugs used in malaria,
KALA-AZAR, amebiasis and
intestinal helminthiasis
Drugs for Kala azar SGL
(Batch A to H)
--
29-10-21 Fri
PA 21.1
Normal hemostasis
SDL
MI2.5.2 Kala azar SGL
HI--Patthology(nesting)
VI-- Gen medicine
--
30-10-21 Sat MI 2.7.1 HIV SDL
PA 21.2
Pathology of vascular
and platelet disorders
including ITP and
haemophilia
SGL
VI - Pediatrics
(nesting)
IM 4.6Discuss and describe
the pathophysiology and
manifestations of
malaria
--
31-10-21 Sun
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
MI 8.11 Performance of lab ess DOAP
Pathology Formative assesment 7
MI 8.10 Methods of collecion of sample DOAP
PA 19.5
Identify and describe the features of Hodgkin's
lymphoma in a gross and microscopic specimen
DOAP
PH 3.2 Perform and interpret a critical appraisal (audit)
of a given prescription (1)
PA 19.7
Identify and describe the gross specimen of an enlarged
spleen
DOAP
PH3.5 To prepare and explain a list of P-drugs for a
given case/condition DOAP (1)
Sunday
Sunday
01-11-21 Mon
PH 1.19 Describe the mechanism/s
of action, types, doses, side
effects,
indications and contraindications
of the drugs which act on CNS,
(including anxiolytics, sedatives &
hypnotics, anti-psychotic,
antidepressant
drugs, anti-maniacs, opioid
agonists and antagonists,
drugs used for neurodegenerative
disorders, anti-epileptics drugs)
Anti-anxiety,antimanic drugs
Lecture
SU11.1 Describe principles
of Preoperative
assessment.
Lecture
FM 2.22.1 to 2.22.5
Trumatic Asphyxia,
Obstruction of nose and
mouth, Suffocation and
sexual asphyxia - Describe
and discuss
patthophysiology, c/f, PM
findings and medicolegal
aspects.
SGL
Pathology Formative
assesment 7
Feedback
--
02-11-21 TueCM 8.3.9 NRHM
SGL
PH5.3 Motivate patients
with chronic diseases to
adhere to the prescribed
management by the health
care provider
SGL (Batch A to H)
--
03-11-21 Wed
PA 21.3
Differentiate platelet from clotting
disorders based on the clinical
and hematologic features
Lecture
VI Medicine (nesting)
MI 8.12 ppatientt
confidentiality SGL--
04-11-21 Thu
05-11-21 Fri
06-11-21 Sat
07-11-21 Sun
08-11-21 Mon
11.4 CM 11.4 Describe the
principle of ergonomics in
healtth ppreservation
SGL
PA 21.4
Pathology of disseminated
intravascular coagulation
Lecture
VI - Medicine (nesting)
--
09-11-21 Tue
CM 8.3.7 NATIONAL PROGRAM
FOR CONTROL OF BLINDNESS
SGL
PA 21.5
Pathology of Vitamin K
deficiency SGL
VI - Medicine (nesting)
--
10-11-21 Wed
PH1.54 Describe vaccines and
their uses
SDL
FM 2.23.1 to 2.23.5
Describe and discuss
types, pathophysiology,
clinical features, PM
findings and medico legal
aspects. Diatom test,
Gettler test., AM PM
drowning, Fresh water and
salt water.SDL
PA 23.3.1
Semen analysis
SGL
PA 23.3.2
Thyroid function tests
SGL
--
11-11-21 Thu
IM 9.12 Describe, develop a
diagnostic plan to determine the
aetiology of
anemia
CM 8.3.8 National leprosy
eradication program
SGL
--
PA 20.1
Describe the features of plasma cell myeloma
DOAP
PH 4.2 Demonstrate the effects of drugs on blood
pressure (vasopressor and vaso-depressors with
appropriate blockers) using computer aided learning (4)
DOAP(Batch A to H)
Clinical Posting
Clinical Posting
Clinical Posting
Deepawali
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
MI 8.14 Pattient confedentialiy DOAP VI AETCOM
PH3.5-To prepare and explain a list of P-drugs for a
given case/condition (3)
DOAP (Batch A to H) Revisioin
Pharmacology Formative
Assessment- 5
Sunday
AITO
AnemiaFri
PA 13.1
Normal hematopoiesis and
extramedullary hematopoiesis
SDL
PY2.1 and 2.2 - Describe the
composition of blood components
and synthesis and function of
hemoglobin
PA 13.3
Classification of anemia
Lecture
PY 2.3 and BI 6.12 -
Describe variants of
haemoglobin and their
physiological/ pathological
relevance.
IM 9.2 - Prevelance of each
of the ca
uses of anemia
PY2.5 Different types of
anemia
MI 2.4........ Pathogenesis
of anemia caused due to
infectious agents
--
13-11-21 Sat
PA 13.4
Laboratory investigation in a case
of anemia
Lecture
IM 9.6 and 9.12 - Appropriate
diagnostic plan and work up
based on presumed etiology of
anemia
Linker case Part 1
OG 12.2.1 Define, classify and
describe the etiology,
pathophysiology,
diagnosis, investigations of
anemia in pregnancy
PE 29.1 Approach to child with
anaemia Lecture
CM 5.6 important
national nutritional Programs including
the Integrated Child
Development Services Scheme (ICDS)
etc LECTURE
PA 14.1
Iron metabolism
SGL
BI 6.11 - Metabolism of
haem PE
13.1 - RDA, nutritional
sources of iron
PA 14.2
Etiology, investigations and
differential diagnosis of
microcytic hypochromic
anemia
SGL
IM 9.8 - Various tests for
iron deficiency anemia
MI2.4..... Pathogenesis of
MH by infectious agents
--
14-11-21 Sun
15-11-21 Mon
PA 15.1
Normal Vitamin B12 metabolism
and pathological aspects of
vitamin B12 deficiency
SGL
IM 9.9 - Interpretation of
hemogram, red cell indices and
B12 and folate levels
BI 6.5 - Vitamins
MI2.4..... Pathogenesis of
macrocytic anemia caused by
infectious agents
PA 15.2 and 15.4
Laboratory investigations
in a case of different forms
of macrocytic anemia.
SGL
IM 9.9 - Tests for B12 and
folate
--
16-11-21 Tue
MI 2.4.1 Microbial agents in
anemia Lecture
HI--Patthology(sharing)
VI-- Gen medicine
IM 9.17 Describe the
indications for blood
transfusion and the
appropriate
use of blood components
--
17-11-21 Wed
PA 16.1
Classification and introduction to
hemolytic anemia Lecture
VI - Biochemistry, General
Medicine BI
5.2 Structure - function
relationship of hemoglobin in
hemoglobinopathies
PA 16.2 and PA 16.4
Pathological aspects and
laboratory investigation of
hemolytic anemia
SGL
BI 5.2 and MI 9.5
--
PA 16.3 and PA 16.5
Describe the pathogenesis, features, hematologic
indices and peripheral blood picture of sickle cell
anemia, thalassemia and other hemolytic anemia
SGL
IM 9.5 Differential diagnosis of anemia based on clinical
features BI 5.2
MI 2.4.......... Pathogenesis of hemolytic anemia caused
by infectios agents
Sunday
PA 14.3
Identify and describe the peripheral smear in microcytic
anemia
DOAP (Batch A to H)
IM - 9.10
PA 15.3
Identify and describe the peripheral blood picture of
macrocytic anemia
DOAP
Clinical Posting
Clinical Posting
PA 13.5
Perform, Identify and describe the peripheral blood
picture in anemia
DOAP (Batch A to H)
VI - IM 9.7 Meaning and utility of various components of
the hemogram report
Clinical Posting
Clinical Posting
18-11-21 Thu
PA 17.1
Pathology and laboratory
investigations in a case of aplastic
anemia. Lecture
PA 17.2
Bone marrow aspiration
and biopsy - Indications
and findings
SGL
IM 9.11 Interpret results of
bone marrow
Linker case - Part B
PA 13.2 Role
of anticoagulants in
hematology practice
SGL
VI - Medicine
--
19-11-21 Fri
20-11-21 Sat
PH 1.35 Describe the mechanism/s
of action, types, doses, side
effects,
indications and contraindications
of drugs used in hematological
disorders like:
1. Drugs used in anemias
2. Colony Stimulating factors
Drugs used in anemia
Lecture
VI--Gen.Med., Phy.
PA 16.7
Describe the correct
technique to perform
a cross match
SGL
OG 12.2.2 Describe adverse effects
on the mother and foetus
and the management during
pregnancy and labor, and
complications of anemia in
pregnancy
--
21-11-21 Sun
22-11-21 Mon MI 4.2.1 Staphylococcus SDL
PH 1.35 Describe the
mechanism/s of action,
types, doses, side effects,
indications and
contraindications of drugs
used in hematological
disorders like:
1. Drugs used in anemias
2. Colony Stimulating
factors
Colony Stimulatting factors
Lecture
VI--Gen.Med., Phy.
--
23-11-21 Tue
PH1.22- Describe drugs of abuse
(dependence, addiction,
stimulants,
depressants, psychedelics, drugs
used for criminal offences)
Lecture
VI-Psychiatry (Nesting)
HI-Forensic Med.(Nesting)
MI2.4.2 Anemia SGL
HI--Patthology(sharing)
VI-- Gen medicine
--
24-11-21 WedCM 8.3.10 NUHM
SGL
Pharmacology
Formative Assessment -
5 Feed
back
--
25-11-21 Thu
MI4.1.2 Clostridium tetani and
Clostridium botulinum
Lecture
VI General Medicine
PH1.8-Identify and describe
the management of drug
interactions
SGL ((Batch A to H)
--
26-11-21 FriCM 8.3.11 Janani Suraksha Yojana
SGL
CM 8.3.13 IMNCI (Age upto
2 mnths to 5 years)
SGL
--MI3.2.5 E hisolytica DOAPClinical Posting
Clinical Posting Microbiology Formtive assesment 5
PA 16.6
Prepare a peripheral blood smear and
identify hemolytic anaemia from it
DOAP
Formative assesment Theory - AITo
anemia
PH 3.1 Write a rational, correct and legible generic
prescription for a given condition and communicate the
same to the patient for anemia (5)
DOAP(Batch A to H)
Clinical Posting
Clinical Posting
Formative assesment Skill - AITo anemia
Clinical Posting
PH 3.2 Perform and interpret a critical appraisal (audit)
of a given prescription (2)
Sunday
Guru Nanak Jayanti
Clinical Posting
27-11-21 Sat
PH1.56-Describe basic aspects of
Geriatric and Pediatric
pharmacology. Drug for Pediatric
Pharmacology (2) Lecture
VI-Pediatrics (Nesting)
PA 7.1
General
charactteristics of
neoplasia - Revision
SGL
CM 8.3.12 IMNCI (Age
upto 2 months)
SGL
Microbiology
Formatave
assesment Feedback
4 and 5
CM 19.1 & 19.2 Define and describe the concept of International health and Describe roles of various international health agencies SGL
MI 8.1.5 Zoonotic
disease- Brucella
SGL(Batch A to H)
VI General Medicine
PH1.4.Pharmacokinetics
SDL--
28-11-21 Sun
29-11-21 Mon MI 6.1.3 TB SDL
CM 8.3.14 Ayushman
bharat yojana
SGL
--
30-11-21 Tue
PA 13.4
Investigation in a case of anemia
Revision
SDL
PH.1.63- Describe Drug
Regulations, acts and other
legal aspects
SGL (Batch A to H)
--
01-12-21 Wed
CM 4.1.1 Describe various
methods of health education
SDL
MI 8.13 Lab tests SGL --
02-12-21 Thu
PH1.56-Describe basic aspects of
Geriatric and Pediatric
pharmacology. Drug for Geriatric
Pharmacology (1) Lecture
MI 8.6.2 Needle sick injury
SGL--
03-12-21 FriMI 4.2 3 to MI 4.3.4 Mycetoma
and dermatopphyes SDL
PH5.6-Demonstrate ability
to educate public &
patients about various
aspects of drug use
including drug dependence
and OTC drugs
SGL (Batch A to H)
VI-Psychiatry (Nesting)
PH1.62-Describe and
discuss antiseptics and
disinfectants
SGL (Batch A to H)
MI 8.15 Resuls of lab tests
SGL--
04-12-21 Sat MI 8.6.1 BMW SDL
PH1.57-Describe
drugs used in skin
disorders.
Lecture
VI-
Dermatalogy(Nesting)
CM 8.3.16 RMNCH+A
SGL
ffformattive
assesment OG --
1formative
assesment
gynecology 1
MI 3.7.3 Biomarker of
hepatitis virus SGL --
05-12-21 Sun
06-12-21 Mon MI 3.7 to MI 3.8 Hepatitiis viruses SDL
PH1.64-Describe overview
of drug development,
Phases of clinical trials
and Good Clinical Practice
SGL((Batch A to H)
--
07-12-21 Tue
PA 18.2
Laboratory investigation in a case
of leukemia SDL
MI 3.7.4 Biomarkers of
hepatitis virus SGL --
08-12-21 WedCM 8.3.17 INAP
SGL
PA 25.4
Alcoholic liver disease
including cirrhosis
Revision
SDL
PA 4.1
General features of acute
inflammation - Revision
SGL
PH5.2-Communicate with
the patient regarding
optimal use of a)
drugtherapy,
b) devices and c) storage of
medicines SGL (Batch A to
H)
--
Clinical Posting
Pathology Formative assesment test 8
PH3.2-Perform and interpret a critical appraisal (audit)
of a given
(3) prescription
DOAP (Batch A to H)
Clinical Posting
Clinical Posting
PH3.3-Perform a critical evaluation of the drug
promotional literature(2)
DOAP (Batch A to H)
PH3.8-Communicate effectively with a patient on the
proper use of
prescribed medication
DOAP (Batch A to H)
Clinical PostingPH4.2- Demonstrate the effects of drugs on blood
pressure (vasopressor and vaso-depressors with
appropriate blockers) using computer aided learning (5)
Clinical Posting
MI 8.7.3 Hand hygience DOAP
HI--Community MEDICINE
VI-- Gen SURGERY
Clinical PostingPA 23.3
Describe and interpret abnormalities in a panel of semen
analysis, thyroid function tests, renal function tests or
Sunday
Clinical Posting
Clinical Posting
Sunday
09-12-21 Thu
PA 28.2.7
Urinary findings in renal failure -
Revision SGL
PH5.4-Explain to the patient
the relationship between
cost of treatment
and patient compliance
SGL (Batch A to H)
VI-Gen.Med.
--
10-12-21 Fri
PA 26.1
Pathology of Pneumonias
Revision SDL
Pathology FAT 8
Feedback--
11-12-21 Sat
PH1.41-Describe the mechanisms
of action, types, doses, side
effects,
indications and contraindications
of uterine relaxants and stimulants
Lecture
VI-Obs Gynae.
CM 15.1 & 15.2 Define
& describe concept of
mental health
&warning signals of
mental health
disorders
LECTURE
FORMATIVE ASSESMENT
MEDICINE -1--
12-12-21 Sun
13-12-21 Mon
PA 27.4 Pathology of
rheumatic heart disease
SDL
Pharmacology
Formative
assesment 6
Feed Back
--
14-12-21 Tue PH1.5 Pharmacodynamic SDLPA 30.1
Carcinoma cervix Revision
SDL
CM 8.3.18 & 15.3 National
Mental Health Programme
SDL
MI 8.4.1 Emerging infectious diseases
Campylobacter SGL--
15-12-21 Wed PH1.30 Anti-arrhythmic drugs 1 LecturePA 28.3 and 28.4
Renal failure - Revision
SGL
CM 13.3 & 13.4 Describe
man made disaster &
national disaster
management authority
SDL
PH1.30 Anti-arrhythmic drugs 2 Lecture --
16-12-21 Thu
PA 28.6
Define and describe the etiology,
pathogenesis….. Of IgA nephropathy
Lecture
PA 30.9
Pathology of endometrial
hyperpplasia
Revision SDL
CM 13.1 & 13.2 Define and
describe the concept of
disaster management &
Disaster management cycle
SDL
MI 8.4.1 Emerging infectious
diseases Ebola, Marburg SGL--
17-12-21 Fri MI 6.1.5 Chlamydia SGLPH 1.42 Sulfonamides and Co-
trimoxazole SGL--
18-12-21 Sat MI5.2.2 JE encephalitis Lecture
CM 4.2.1 Describe the
methods of
organizing health
promotion and
education activities at
individual, family &
community setting.
SDL
PH 1.42 Aminoglycosides 1
SGL
PA 28.7
Glomerular
manifestattion of
systemic disease Lecture
PA 28.8
Tubulo-interstitial diseases of
kidney SGL
--
19-12-21 Sun
PA 23.3
Describe and interpret abnormalities in a panel of semen
analysis, thyroid function tests, renal function tests or
liver - Revision
DOAP
PH2.2-Prepare oral rehydration solution from ORS
packet and explain its use
DOAP (Batch A to H)
PH 4.2 Demonstrate the effects of drugs on blood
pressure (vasopressor and vaso-depressors with
appropriate blockers) using computer aided learning (6)
DOAP(Batch A to H)
PA 25.6
Interpret liver function test report and viral hepatitis
serology panel - Revision
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting Pharmacology Formative assesment-6
Clinical PostingPH3.3-Perform a critical evaluation of the drug
promotional literature(3) DOAP (Batch A to H)
Sunday
MI 8.7.2 PPE DOAP
Sunday
20-12-21 MonMI 4.3.2 Atypical mycobacteria
Lecture
FM 2.24.1 to 2.24.3
Describe the clinical features, PM
findings, ML aspects of injuaries
due to physical agents like heat
(heat stroke, heat cramps, etc.)
or cold systemic and localised
hypothermia. Lecure
--
21-12-21 Tue Formative assesment Feedback
PA 28.9
Acute ttubular necrosis
SGL
PH 1.42 Aminoglycosides 2
SGLMI 8.5.1 HAI SGL --
22-12-21 Wed
CM 4.2.2 Describe the methods of
counselling activites at individual,
family & community setting.
SDL
MI 8.5.2 Factors conributing HAI
SGL--
23-12-21 Thu
FM 2.25.1 to 2.25.3
Describe type of injuries C/F,
Pathophysiology, PM findings and
Medicolegal aspects in case of burns,
scalds , lightining, electricution, radiation.
Lecture
MI 2.5.6 Lab diagnosis of
filariasis SGL--
24-12-21 Fri
FM 2.25.4 to 2.25.12 Differentiate
between AM burn and PM burn, Calculate
extent of burn and document and
inerpret PM findings in case of burns,
Lecture
PA 34.3
Pathology of Malignant
Melanoma
SGL
--
25-12-21 Sat
26-12-21 Sun
27-12-21 Mon
28-12-21 Tue
29-12-21 Wed
30-12-21 Thu
31-12-21 Fri
01-01-22 Sat
02-01-22 Sun
03-01-22 Mon
04-01-22 Tue
AETCOM FM 4.16 ,FM 4.17.1
Describe & Discuss Bio-etthics Describe &
Discuss Ethical Principles: Respect for
autonomy,non-malfeasance, beneficence
& jusice. LecturePA 34.1 Pathology of
squamous cell cacinoma
of skin Lecture
PH3.7 Essential drug
list DOAP
FM 1.9.1 & 1.9.2
Importance of documentation
and their importances in
medical practices in regards to
medico legal examinations
SGLCM 11.3 Enumerate and
describe the occupational
health hazards their risk
factors and preventive
measures LECTURE
--
05-01-22 WedCM 8.3.15 RBSK
SGL
FORMATIVE ASSESMENT
MEDICINE 2
FM FM FM--
06-01-22 Thu FM FM --
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
Clinical Posting
PA 34.4 Common
tumours of skin DOAP
Christmas
IIIrd Terminal
PH 2.2 Prepre ORS packet DOAP
PH 2.3 Setting up of IV drip set DOAP
PH 2.4 Calculattion of drug dosages DOAP
PH 1.12 calculatioin of drug dosages using appropriate
formulae DOAP
MI 5.3.2 Meningitis LCB DOAP
PH2.4 calculation of drug dosage DOAP
Clinical Posting
Sunday
07-01-22 Fri
FM
FORMATIVE ASSESMENT OG-2
CM 4.1.2 Advantages
and limitations of
health education
methods
SDL
FM FM
--
08-01-22 Sat --09-01-22 Sun
10-01-22 Mon
11-01-22 Tue
12-01-22 Wed
13-01-22 Thu --14-01-22 Fri --15-01-22 Sat --16-01-22 Sun
17-01-22 Mon
18-01-22 Tue
19-01-22 Wed
20-01-22 Thu
21-01-22 Fri
22-01-22 Sat
23-01-22 Sun
24-01-22 Mon --25-01-22 Tue --26-01-22 Wed --27-01-22 Thu
28-01-22 Fri
29-01-22 Sat
30-01-22 Sun
Subjects Lectures
(hours)
Small group Teaching /
Tutorials
Integrated learning practical
(hours)
Self directed learning
(hours)
Total
(hours)
COMMUNITY MEDICINE 20 30 10 60
PATHOLOGY 80 140 12 232
MICROBIOLOGY 74 115 11 200
PHARMACOLOGY 80 138 12 230
SURGERY 25 -- -- 25
MEDICINE 27 -- -- 27
OBS & GYNAECOLOGY 25 -- -- 25
CLINICAL POSTING -- -- 540
AETCOM 37 -- -- 37
Sports and Extra-curricular activities 37 -- -- 37
FORENSIC MEDICINE 15 30 5 50
Pandemic Module -- 28TOTAL -- -- -- 1491
Copy to :- Prof. M.Z. Idris
Director- Hospital Dean/DirectorIMS&R,
All HODs, IIMSR Integral University, Lucknow
Medical Education Unit
Remedial
Professional
Professional Practical
PH 3.4 Recognize and report an ADR DOAP
Sunday
Sunday
Sunday